KR20170126059A - Organic compound comprising pyrimidine and organic electroluminescent device comprising the same - Google Patents

Organic compound comprising pyrimidine and organic electroluminescent device comprising the same Download PDF

Info

Publication number
KR20170126059A
KR20170126059A KR1020160055435A KR20160055435A KR20170126059A KR 20170126059 A KR20170126059 A KR 20170126059A KR 1020160055435 A KR1020160055435 A KR 1020160055435A KR 20160055435 A KR20160055435 A KR 20160055435A KR 20170126059 A KR20170126059 A KR 20170126059A
Authority
KR
South Korea
Prior art keywords
compound
substituted
group
unsubstituted
organic
Prior art date
Application number
KR1020160055435A
Other languages
Korean (ko)
Other versions
KR101977352B1 (en
Inventor
박정규
장순욱
이현석
김민영
전영민
Original Assignee
대주전자재료 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대주전자재료 주식회사 filed Critical 대주전자재료 주식회사
Priority to KR1020160055435A priority Critical patent/KR101977352B1/en
Publication of KR20170126059A publication Critical patent/KR20170126059A/en
Application granted granted Critical
Publication of KR101977352B1 publication Critical patent/KR101977352B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38[b, e]-condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/20[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • H01L51/0071
    • H01L51/5056
    • H01L51/5072
    • H01L51/5092
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/16Electron transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • H10K50/171Electron injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to an organic aromatic organic compound containing pyridine, and an organic electroluminescent device using the same, wherein the compound may be used as thermally activated delayed fluorescent (TADF) material due to having little energy difference between an excited singlet state and an excited triplet state. Further, the compound of the present invention may be used in an organic light-emitting diode to improve efficiency of the organic light-emitting diode and lower driving voltage thereof.

Description

피리미딘을 포함하는 유기 화합물 및 이를 포함하는 유기전기발광소자{Organic compound comprising pyrimidine and organic electroluminescent device comprising the same}[0001] The present invention relates to organic compounds containing pyrimidines and organic electroluminescent devices comprising the same,

본 발명은 발광 효율이 우수한 신규한 발광재료, 및 이를 하나 이상의 유기층에 포함함으로써 우수한 효율 특성을 나타내는 유기전기발광소자에 관한 것이다.The present invention relates to a novel luminescent material having excellent luminescent efficiency and an organic electroluminescent device exhibiting excellent efficiency characteristics by incorporating it into one or more organic layers.

유기 반도체는 다양한 유형의 수많은 전자 장비 응용을 위해 개발되고 있다. 유기 전기발광 소자는 기존 액정 표시 장치(LCD), 플라즈마 디스플레이 패널(PDP) 및 전계 방출 디스플레이(FED) 등의 타 평판 표시 소자에 비해 구조가 간단하고, 제조 공정상 다양한 장점이 있으며 높은 휘도 및 시야각 특성이 우수하며, 응답속도가 빠르고 구동전압이 낮아 벽걸이 TV등의 평판 디스플레이 또는 디스플레이의 배면광, 조명, 광고판 등의 광원으로서 사용되도록 활발하게 개발이 진행되고 있다.Organic semiconductors are being developed for many types of electronic equipment applications. The organic electroluminescent device has a simple structure compared to other flat panel display devices such as a liquid crystal display (LCD), a plasma display panel (PDP), and a field emission display (FED) And has a high response speed and a low driving voltage, so that it is being actively developed to be used as a light source for a flat panel display such as a wall-mounted TV or a backlight of a display, a lighting, and a billboard.

유기 전기발광 소자는 일반적으로 직류전압을 인가하였을 때 양극으로부터 주입된 정공과 음극으로부터 주입된 전자가 재결합하여 전자-정공 쌍인 엑시톤을 형성하며 이 엑시톤의 에너지를 발광 재료에 전달함에 의해 빛으로 변환된다.In the organic electroluminescent device, when a direct current voltage is applied, holes injected from the anode recombine with electrons injected from the cathode to form an exciton, which is an electron-hole pair, and the energy of the exciton is transferred to the light emitting material .

일반적으로, 유기전기발광소자는 음극(전자주입전극)과 양극(정공주입전극), 및 상기 두 전극 사이에 하나 이상의 유기층을 포함하는 구조를 갖는다. 이때, 유기전기발광소자는 유기층으로서 발광층(EML, light emitting layer) 이외에, 정공주입층(HIL, hole injection layer), 정공수송층(HTL, hole transport layer), 전자수송층(ETL, electron transport layer) 또는 전자주입층(EIL, electron injection layer)을 포함할 수 있으며, 발광층의 발광특성상, 전자차단층(EBL, electron blocking layer) 또는 정공차단층(HBL, hole blocking layer)을 추가로 포함할 수 있다. 이들 유기층을 모두 포함하는 유기전기발광소자는 양극/정공주입층/정공수송층/전자차단층/발광층/정공차단층/전자수송층/전자주입층/음극 순으로 적층된 구조를 갖는다.In general, an organic electroluminescent device has a structure including a cathode (electron injection electrode), an anode (hole injection electrode), and at least one organic layer between the two electrodes. In this case, the organic electroluminescent device may include, as an organic layer, a hole injection layer (HIL), a hole transport layer (HTL), an electron transport layer (ETL), or an electron transport layer And may further include an electron injection layer (EIL), and may further include an electron blocking layer (EBL) or a hole blocking layer (HBL) on the light emitting property of the light emitting layer. The organic electroluminescent device including all of these organic layers has a stacked structure in the order of anode / hole injecting layer / hole transporting layer / electron blocking layer / light emitting layer / hole blocking layer / electron transporting layer / electron injecting layer / cathode.

이러한 구조의 유기전기발광소자에 전기장을 인가하면, 양극으로부터 주입된 정공과 음극으로부터 주입된 전자가 재결합(recombination)하여 전자-정공 쌍인 엑시톤(exiton)을 형성하며, 이 엑시톤의 에너지가 발광 재료에 전달됨에 따라 빛이 방출된다.When an electric field is applied to the organic electroluminescent device having such a structure, the holes injected from the anode and the electrons injected from the cathode are recombined to form an electron-hole pair exciton, Light is emitted as it is transmitted.

발광재료는 크게 그 빛을 내는 원리에 따라 형광발광재료와 인광발광재료 그리고 최근 아다치 그룹을 중심으로 연구되고 있는 지연 형광(TADF)로 구분되며 다시 색깔별로 구분이 될 수 있다. 일반적으로 발광재료는 빛의 삼원색인 적색·녹색·청색만 있으면 우리가 원하는 거의 모든 색을 발현할 수 있으나 빛을 혼합하는 경우 흰색에 가까워져 색도가 떨어지는 경우가 있으므로 완벽한 풀 컬러 구현을 위해서는 노란색과 주황색을 구비하는 것이 좋다. 또한 발광재료로 한 물질만을 적용하는 경우 색순도와 발광효율이 떨어지는 단점이 있으므로 호스트의 발광스펙트럼과 도펀트의 흡수스펙트럼이 일치하는 호스트/도펀트 계를 이용하여 도펀트 단독으로 사용하였을 때 보다 색순도와 발광효율을 증가시키는 경우로 호스트 재료와 도펀트 재료가 있다.The luminescent materials are classified into phosphorescent materials, phosphorescent materials, and delayed fluorescence (TADF), which is recently studied mainly in the Adachi group, according to the principle of emitting light. Generally, a light emitting material can emit almost all the colors that we desire with only the three primary colors of light: red, green, and blue. However, when mixing light, . In addition, there is a disadvantage in that the color purity and luminous efficiency are inferior when a single material is used as a light emitting material. Therefore, the host / dopant system in which the emission spectrum of the host and the absorption spectrum of the dopant are coincident, There are host materials and dopant materials to increase.

특히 고효율의 아몰레드를 상용화하기 위해서는 효율 측면의 문제를 해결해야 하며 특히 청색과 녹색 발광재료의 효율향상이 필요하다. 그러나 청색발광재료의 경우 형광재료를 사용하게 되면 구조적인 문제로 인해 5%를 넘기 힘든 실정이며 인광재료의 사용을 통해 효율 향상을 기대할 수밖에 없었다. 그럼에도 인광재료의 개발이 어려운 이유는 높은 효율을 가짐에도 불구하고 인광을 구현하기 위해 필요한 금속착화합물 (Ir, Pt 등)의 비용이 너무 비싸고 수명이 매우 짧아 상용화에 문제가 되기 때문이다. 그러나 최근『Nature』(2012,492, 234) 및『JACS』(2012, 134, 14706)에 발표된 논문에서 TADF (Thermally Activated Delayed Fluorescence)의 개념을 도입하여 형광재료이면서도 외부양자효율이 높은 고효율 녹색 형광 재료를 발표하여 이슈가 되고 있다. TADF 개념은 여기 삼중항 상태로부터 여기 단일항 상태로의 역 에너지 이동을 열 활성화에 의해서 생기게 하여 형광 발광에 이르는 현상을 말한다. 삼중항 경유로 발광이 생기기 때문에 일반적으로 수명이 긴 발광이 생기는 점에서 지연 형광으로 부른다. 전자를 공여하기 쉬운 성질(donor)과 전자를 받기 쉬운 성질(acceptor)을 가지고 있는 분자 구조를 조합하여 단일항과 삼중항의 여기상태의 에너지 차이를 작게 하는 분자 설계를 통해 고효율인 TADF 개념에 적합한 재료의 개발이 가능하다. TADF의 장점은 형광발광과 인광발광을 모두 사용할 수 있다는 점이며 이를 통해 기존의 형광재료가 가지는 외부양자효율의 문제점을 해결할 수 있다는 점에서 형광과 인광을 이은 제 3세대 재료로 많은 관심을 받고 있다.Particularly, in order to commercialize amorphous high-efficiency amorphous, the problem of efficiency must be solved, and in particular, the efficiency of blue and green light emitting materials needs to be improved. However, in the case of a blue light emitting material, it has been difficult to exceed 5% due to a structural problem when a fluorescent material is used, and it is inevitable to expect efficiency improvement through the use of a phosphorescent material. Nevertheless, it is difficult to develop a phosphorescent material because the cost of the metal complex (Ir, Pt, etc.) required to realize phosphorescence is too high and the life is very short, which is a problem in commercialization. However, recently, the paper published in Nature (2012, 492, 234) and JACS (2012, 134, 14706) introduces the concept of Thermally Activated Delayed Fluorescence (TADF) It has become an issue by presenting fluorescent materials. The TADF concept refers to the phenomenon that the inverse energy transfer from the excitation triplet state to the excited singlet state is caused by thermal activation resulting in fluorescence emission. Since triplet light oil emits light, it is generally called delayed fluorescent light in that long-lived light emission occurs. A material suitable for the high-efficiency TADF concept through molecular design that reduces the energy difference between singlet and triplet excited states by combining electron donor and acceptor electron acceptor molecule Can be developed. The advantage of TADF is that it can use both fluorescent and phosphorescent luminescence, and it has been attracting much attention as a third-generation material with fluorescence and phosphorescence in that it can solve the problems of external quantum efficiency of existing fluorescent materials .

TADF개념을 도입한 재료는 유기 화합물의 분자설계의 자유도를 살리면서도 비교적 단순한 분자구조에서 여기 전자상태를 제어할 수 있음이 밝혀졌다. 이에 따라서 유기 발광재료에서 구조 디자인 설계의 폭이 넓어지면서, 유기 발광 소자의 실용화와, 고효율 RGB 발광 재료의 마련, 고내구성의 소자를 실현할 수 있을 것으로 기대되고 있다. The TADF concept has been shown to be able to control the excited state of electrons in a relatively simple molecular structure while taking advantage of the freedom of molecular design of organic compounds. As a result, the width of the structural design design in the organic light emitting material is widening, and it is expected that practical use of the organic light emitting device, provision of high-efficiency RGB light emitting material, and high durability are realized.

이에 본 발명자는 신규 TADF 발광재료를 개발하기 위해 예의 연구 노력한 결과, 피리미딘을 포함하는 신규 발광재료를 설계하여 본 발명을 완성하게 되었다.Accordingly, the present inventors have made intensive research to develop a novel TADF luminescent material, and as a result, they have completed the present invention by designing a novel luminescent material containing pyrimidine.

본 발명의 목적은 유기발광 다이오드 효율 향상 및 구동 전압 감소를 기대할 수 있는 신규한 발광재료 및 이를 유기층에 포함하는 유기발광소자를 제공하는 것이다.It is an object of the present invention to provide a novel light emitting material which can be expected to improve the efficiency of the organic light emitting diode and reduce the driving voltage, and an organic light emitting device including the organic light emitting diode.

본 발명의 목적은 TADF 발광재료로 사용가능한 화합물, 및 이를 유기층에 포함하는 유기발광소자를 제공하는 것이다.It is an object of the present invention to provide a compound which can be used as a TADF light emitting material, and an organic light emitting element containing the same in an organic layer.

상기 과제를 해결하기 위해, 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:In order to solve the above-mentioned problems, the present invention provides a compound represented by the following formula (1):

[화학식 1][Chemical Formula 1]

Figure pat00001
Figure pat00001

상기 식에서, In this formula,

R1은 단일결합, -CH2-, S 또는 O이고, 상기 R2 내지 R3은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 치환된 탄소수 6 내지 40의 아릴기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기, 치환 또는 비치환된 탄소수 2 내지 60의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 60의 알키닐기, 치환 또는 비치환된 탄소수 3 내지 60의 시클로알킬기 및 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기 중에서 선택되는 어느 하니이고,R 1 is a single bond, -CH 2 -, S or O, each of R 2 to R 3 independently represents hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted group having 6 to 40 A substituted or unsubstituted aryl group having 2 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 60 carbon atoms, a substituted or unsubstituted alkynyl group having 2 to 60 carbon atoms, A cycloalkyl group having 3 to 60 carbon atoms, and a substituted or unsubstituted cycloalkenyl group having 5 to 30 carbon atoms,

임의적으로 상기 R1 내지 R3은 각각 독립적으로 탄소수 1 내지 6의 알킬로 치환 또는 비치환된 탄소수 6 내지 50의 아릴, 탄소수 1 내지 50의 알킬 및 탄소수 3 내지 50의 사이클로알킬로 구성되는 군으로부터 선택되는 어느 하나 이상의 치환기로 치환될 수 있다.Optionally, R 1 to R 3 are each independently selected from the group consisting of C 6 -C 50 aryl, C 1 -C 50 alkyl, and C 3 -C 50 cycloalkyl substituted or unsubstituted with alkyl having 1 to 6 carbons And may be substituted with any one or more substituents selected.

바람직하게는, 상기 R2 및 R3는 각각 독립적으로 수소, 중수소, 카바졸(carbazole), 아크리딘(droacridine), 페노시아진(phenothiazine), 페녹사진(phenoxazine), 디벤조퓨란(dibenzofuran), 디벤조티오펜(dibenzothiophene) 및 페닐카바졸(phenylcarbazole)로 이루어진 군에서 선택되는 어느 하나이고, Preferably, R 2 and R 3 are each independently selected from the group consisting of hydrogen, deuterium, carbazole, droacridine, phenothiazine, phenoxazine, dibenzofuran, , Dibenzothiophene, and phenylcarbazole. The compound of formula (I)

R1, R2 및 R3는 서로 결합하여 잔텐(xanthene)을 형성할 수 있고,R 1 , R 2 and R 3 may combine with each other to form a xanthene,

R2 및 R3는 각각 인접한 탄소와 결합하여 벤조퓨란(benzofuran), 벤조티오펜(hydrobenzothiophene), 인덴(indene) 또는 인돌린(indoline)을 형성할 수 있으며,R 2 and R 3 may each combine with adjacent carbons to form benzofuran, hydrobenzothiophene, indene or indoline,

임의적으로 상기 R1 내지 R3은 각각 독립적으로 탄소수 1 내지 6의 알킬로 치환 또는 비치환된 탄소수 6 내지 50의 아릴, 탄소수 1 내지 50의 알킬 및 탄소수 3 내지 50의 사이클로알킬로 구성되는 군으로부터 선택되는 어느 하나 이상의 치환기로 치환될 수 있다.Optionally, R 1 to R 3 are each independently selected from the group consisting of C 6 -C 50 aryl, C 1 -C 50 alkyl, and C 3 -C 50 cycloalkyl substituted or unsubstituted with alkyl having 1 to 6 carbons And may be substituted with any one or more substituents selected.

이하, 본 발명을 자세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 화학식 1로 표시되는 화합물은 피리미딘에 연결된 공여체와 수용체 치환기들을 갖는 방향족 화합물의 구조를 갖는 것을 특징으로 한다. 본 발명의 화합물은 최저 여기 단일항 상태(S1)의 에너지와 최저 삼중항 상태(T1)의 에너지의 차이가 작아 열활성화 지연 형광(TADF)을 나타낼 수 있다. 예컨대 본 발명의 화합물은 S1과 T1간의 분리가 최대 0.15ev일 수 있다.The compound represented by formula (1) of the present invention is characterized by having a structure of a donor connected to pyrimidine and an aromatic compound having acceptor substituents. The compound of the present invention can exhibit thermally activated delayed fluorescence (TADF) because of a small difference in energy between the lowest excited singlet singlet state (S1) and the lowest triplet state (T1). For example, the compounds of the present invention may have a separation between S 1 and T 1 of at most 0.15 eV.

또한, 본 발명에 따른 화학식 1로 표시되는 화합물 중 피리미딘 분자는 전자 전달 능력을 향상 시킬 수 있으며, 삼중항 상태(T1)의 에너지가 높아 진청색 구현을 할 수 있어서 디스플레이의 색표현 능력을 증대 시킬 수 있을 것으로 기대 할 수 있다.In addition, the pyrimidine molecule of the compound represented by the formula (1) according to the present invention can improve the electron transferring ability and can realize the dark blue color because of the high energy of the triplet state (T1) Can be expected.

상기 화학식 1로 표시되는 화합물의 대표적인 예는 다음과 같다.Representative examples of the compound represented by the formula (1) are as follows.

Figure pat00002
Figure pat00002

Figure pat00003
Figure pat00003

Figure pat00004
Figure pat00004

Figure pat00005
Figure pat00005

Figure pat00006
Figure pat00006

Figure pat00007
Figure pat00007

Figure pat00008
Figure pat00008

상기 화학식 1로 표시되는 화합물은 도입하는 치환기의 종류에 따라 발광층 뿐만 아니라, 정공주입층, 정공수송층, 전자수송층 및 전자주입층 모두에 적용될 수 있다. 정공주입, 정공수송, 정공저지, 발광, 전자수송, 전자주입, 양극과 정공주입층 사이의 완충(buffer) 역할 등을 할 수 있는 화합물들은 다수 공지되어 있으며, 대체로 치환 또는 비치환된 방향족 또는 헤테로 방향족기를 포함하고 있다.The compound represented by Formula 1 may be applied to not only the light emitting layer but also the hole injecting layer, the hole transporting layer, the electron transporting layer, and the electron injecting layer depending on the type of the substituent to be introduced. A number of compounds which can act as a buffer between a hole injection, a hole transport, a hole blocking, a luminescence, an electron transport, an electron injection, and an anode and a hole injection layer are well known and are generally substituted or unsubstituted aromatic or hetero And an aromatic group.

또한, 본 발명의 일례로 하기 반응식 1과 같이 상기 화학식 1로 표시되는 화합물의 제조방법을 제공한다.Also, as an example of the present invention, there is provided a process for producing a compound represented by the above formula (1)

[반응식 1][Reaction Scheme 1]

Figure pat00009
Figure pat00009

상기 반응식 1에서, R1 내지 R3의 정의는 상기에서 설명한 바와 같고, X는 할로겐이다.In the above Reaction Scheme 1, the definitions of R 1 to R 3 are the same as those described above, and X is halogen.

바람직하게는, 상기 X는 염소 또는 브롬이다.Preferably, X is chlorine or bromine.

즉, 본 발명은 하기 화학식 2로 표시되는 화합물과 하기 화학식 3으로 표시되는 화합물을 반응시키는 단계(단계 1)를 포함하는 하기 화학식 1로 표시되는 화합물의 제조방법을 제공한다.That is, the present invention provides a process for preparing a compound represented by the following formula (1), comprising the step of reacting a compound represented by the following formula (2) with a compound represented by the following formula (3)

[화학식 1][Chemical Formula 1]

Figure pat00010
Figure pat00010

[화학식 2](2)

Figure pat00011
Figure pat00011

[화학식 3](3)

Figure pat00012
Figure pat00012

상기 식에서, R1 내지 R3의 정의는 상기에서 설명한 바와 같고, X는 할로겐이다.In the above formula, the definitions of R 1 to R 3 are the same as those described above, and X is halogen.

상기 단계 1은, 화학식 2로 표시되는 화합물과 화학식 3으로 표시되는 화합물을 반응시켜 화학식 1로 표시되는 화합물을 제조하는 단계이다.Step 1 is a step of reacting a compound represented by formula (2) with a compound represented by formula (3) to prepare a compound represented by formula (1).

본 발명에서, 상기 단계 1)의 반응용매로는 톨루엔을 사용할 수 있으며, 이에 제한되는 것은 아니다.In the present invention, toluene can be used as the reaction solvent in the step 1), but is not limited thereto.

본 발명에서, 상기 단계 1)의 반응 온도는 100 내지 130℃인 것이 바람직하다. 만일 상기 반응온도가 100보다 낮으면 반응속도가 느려져 반응시간이 길어지는 단점이 있고, 130보다 높으면 불순물이 생성되고 그로 인해 수율이 저하되는 단점이 있다.In the present invention, the reaction temperature in step 1) is preferably 100 to 130 ° C. If the reaction temperature is lower than 100, the reaction rate becomes slow and the reaction time becomes longer. On the other hand, when the reaction temperature is higher than 130, impurities are formed and the yield is lowered.

본 발명에서, 상기 단계 1)의 반응 시간은 12 내지 20 시간인 것이 바람직하다. 만일 상기 반응시간이 12 시간보다 짧으면 반응이 완결되지 않아 출발물질이 잔류하게 되는 단점이 있고, 통상적으로 반응시간은 20 시간 이내에 완결되기 때문에 20 시간 초과의 반응시간이 필요하지 않다.In the present invention, the reaction time of the step 1) is preferably 12 to 20 hours. If the reaction time is shorter than 12 hours, the reaction is not completed and the starting material remains. In general, the reaction time is completed within 20 hours, so that a reaction time of more than 20 hours is not required.

또한, 본 발명은 화학식 1로 표시되는 화합물, 바람직하게는 상기 화합물 1 내지 33 중 어느 하나의 화합물을 함유하는 유기전기발광소자용 발광 호스트 또는 도판트 함유 조성물을 제공한다.The present invention also provides a luminescent host or dopant-containing composition for an organic electroluminescence device, which contains a compound represented by the formula (1), preferably any one of the above-mentioned compounds (1) to (33).

또한, 본 발명은 화학식 1로 표시되는 화합물, 바람직하게는 상기 화합물 1 내지 33 중 어느 하나의 화합물을 하나 이상의 유기층에 포함하는 유기전기발광소자를 제공한다. 이때, 상기 유기층은 발광층을 필수적으로 포함하며, 발광층 외에도 정공주입층, 정공수송층, 전자주입층, 전자수송층 또는 이들의 적층체를 포함할 수 있다.The present invention also provides an organic electroluminescence device comprising a compound represented by the formula (1), preferably one of the compounds (1) to (33) in at least one organic layer. At this time, the organic layer essentially includes a light emitting layer and may include a hole injecting layer, a hole transporting layer, an electron injecting layer, an electron transporting layer, or a laminate thereof in addition to the light emitting layer.

본 발명의 유기전기발광소자는 양극, 음극, 및 상기 두 전극 사이에 적어도 하나의 발광층을 함유하는 단층 또는 다층으로 이루어진 유기층을 포함하며, 상기 유기층 중 1층 이상의 층이 화학식 1로 표시되는 화합물, 바람직하게는 상기 화합물 1 내지 33의 화합물 중 어느 하나 또는 그 이상의 신규 화합물을 함유한다. 예를 들어, 다층형 유기전기발광소자는 아래부터 기판, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 및 음극의 다층 구조로 적층된다.The organic electroluminescent device of the present invention comprises a single layer or a multilayer organic layer containing a positive electrode, a negative electrode and at least one light emitting layer between the two electrodes, wherein at least one layer of the organic layer is a compound represented by the general formula (1) Preferably one or more of the compounds of the above-mentioned compounds 1 to 33. For example, a multilayer organic electroluminescent device is laminated from the bottom in a multilayer structure of a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, an electron injecting layer and a cathode.

본 발명에 따른 유기전기발광소자의 기판, 양극 및 음극은 통상적인 유기전기발광소자에 사용되는 물질로 이루어지며, 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 어느 한 층은 화학식 1로 표시되는 화합물, 바람직하게는 상기 화합물 1 내지 33 중 어느 하나 또는 그 이상의 화합물 또는 이들의 혼합물로 이루어질 수 있다.The substrate, the anode, and the cathode of the organic electroluminescent device according to the present invention are made of a material used in a conventional organic electroluminescent device, and any one of the hole injecting layer, the hole transporting layer, the light emitting layer, the electron transporting layer, 1, preferably any one or more of the above-mentioned compounds 1 to 33, or a mixture thereof.

특히, 발광층의 경우, 본 발명의 화학식 1로 표시되는 화합물, 바람직하게는 상기 화합물 1 내지 33의 화합물을 단독으로 또는 2가지 이상을 조합하여 사용하거나, 발광 호스트(host) 물질 또는 도판트(dopant) 물질로서 사용하여 공지된 다른 발광 도판트 물질 또는 호스트 물질과 함께 사용할 수 있다. 화학식 1로 표시되는 화합물, 바람직하게는 상기 화합물 1 내지 33의 화합물을 단독 발광물질 또는 호스트 물질로서 사용할 경우에는 발광층 대비 100 내지 80 중량%의 양으로 첨가할 수 있고, 도판트 물질로서 사용할 경우에는 발광층 대비 0.01 내지 20 중량%의 양으로 첨가할 수 있다. 화학식 1로 표시되는 화합물, 바람직하게는 상기 화합물 1 내지 33의 화합물과 함께 발광층에 사용할 수 있는 발광 물질, 호스트 물질 또는 도판트 물질의 구체적인 예로는 안트라센, 나프탈렌, 페난트렌, 파이렌, 테트라센, 코로넨, 크라이센, 플루오레세인, 페릴렌, 프탈로페릴렌, 페리논, 프탈로페리논, 나프탈로페리논, 디페닐부타디엔, 테트라페닐부타디엔, 쿠마린, 옥사디아졸, 알다진, 비스벤족사졸린, 비스스타이릴, 피라진, 사이클로펜타디엔, 퀴놀린 금속 착체, 아미노퀴놀린 금속 착체, 벤조퀴놀린 금속 착체, 이민, 디페닐에틸렌, 비닐안트라센, 디아미노카바졸, 피란, 티오피란, 폴리메틴, 멜로사이아닌, 이미다졸 킬레이트화 옥시노이드 화합물, 퀴나크리돈, 루브렌, 형광 색소 및 이들의 혼합물을 들 수 있지만, 이들에 한정되는 것은 아니다. 도판트 물질을 선택할 경우, 고효율의 형광 또는 인광을 가지면서 호스트 물질의 밴드갭(bandgap)보다 같거나 작은 밴드갭을 갖는 것을 선택하는 것이 바람직하다.Particularly, in the case of the light emitting layer, the compound represented by the formula (1) of the present invention, preferably the compounds (1) to (33) may be used alone or in combination of two or more, or a light emitting host substance or a dopant ) Materials and may be used with other known light emitting dopant materials or host materials. When the compound represented by the formula (1), preferably the compound (1) to (33) is used as a single luminescent material or a host material, it may be added in an amount of 100 to 80% by weight relative to the light emitting layer. May be added in an amount of 0.01 to 20% by weight relative to the light emitting layer. Specific examples of the light emitting material, the host material or the dopant material which can be used in the light emitting layer together with the compound represented by the formula (1), preferably the compound (1) to (33) include anthracene, naphthalene, phenanthrene, But are not limited to, naphthalene, naphthalene, naphthalene, naphthalene, naphthalene, naphthalene, naphthalene, naphthalene, Anthraquinone metal complexes, benzoquinoline metal complexes, imine, diphenylethylene, vinyl anthracene, diaminocarbazole, pyran, thiopyran, polymethine, meloxane, Imidazole chelated oxinoid compounds, quinacridone, rubrene, fluorescent dyes, and mixtures thereof, but are not limited thereto. When a dopant material is selected, it is preferable to select a dopant having a bandgap equal to or less than the bandgap of the host material while having high efficiency of fluorescence or phosphorescence.

유기전기발광소자를 구성하는 각각의 층은 진공 증착, 스퍼터링, 플라즈마, 이온 도금 등의 건식 성막법, 또는 방사 피복, 침지 피복, 유동 피복 등의 습식 성막법 중 임의의 통상적인 방법을 적용하여 형성시킬 수 있다. 막 두께는 특별히 한정되지 않으나, 막 두께가 너무 두꺼우면 일정한 광 출력을 얻기 위해 높은 인가전압이 필요하여 효율이 나빠지고, 막 두께가 너무 얇으면 핀홀(pin hole) 등이 발생하여 전기장을 인가하여도 충분한 발광 휘도가 얻어지지 않는다. 통상적인 막 두께는 5 nm 내지 10 ㎛의 범위가 바람직하나, 50 nm 내지 400 nm의 범위가 더욱 바람직하다.Each of the layers constituting the organic electroluminescent device may be formed by any of a conventional film forming method such as vacuum deposition, sputtering, plasma or ion plating, or a wet film forming method such as spin coating, immersion coating, . If the film thickness is too large, a high applied voltage is required to obtain a constant light output, which leads to deterioration of efficiency. When the film thickness is too thin, pin holes are generated and an electric field is applied A sufficient light emission luminance can not be obtained. A typical film thickness is preferably in the range of 5 nm to 10 mu m, more preferably in the range of 50 nm to 400 nm.

본 발명의 신규 화합물을 유기발광다이오드에 사용하는 경우, 유기발광 다이오드 효율을 향상시키고 구동 전압을 낮출 수 있다.When the novel compound of the present invention is used in an organic light emitting diode, the efficiency of the organic light emitting diode can be improved and the driving voltage can be lowered.

본 발명의 신규 화합물은 전자를 공여하기 쉬운 성질(donor)과 전자를 받기 쉬운 성질(acceptor)을 가지고 있는 분자 구조가 조합됨으로써 단일항과 삼중항의 여기상태 간의 적은 에너지 차이를 나타냄으로써 TADF (열 활성화 지연 형광) 발광재료로 사용될 수 있다. The novel compounds of the present invention exhibit a small energy difference between the excited state of the triplet and the excited state of the triplet by combining donor and donor electron acceptor molecules so that TADF Retarded fluorescence) luminescent material.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for describing the present invention more specifically, and the scope of the present invention is not limited by these examples.

실시예 1: 화합물 1의 제조Example 1: Preparation of Compound 1

하기 반응식으로 화합물 1을 제조하였다.Compound 1 was prepared by the following reaction formula.

Figure pat00013
Figure pat00013

(1) 중간체 C-4의 합성(1) Synthesis of intermediate C-4

본 발명의 핵심 중간체 C-4, 즉 3-(6-브로모피리딘-2-일)이미다조[1,2-α]피리미딘을 다음의 합성 방법으로 합성하였다.The core intermediate C-4 of the present invention, namely 3- (6-bromopyridin-2-yl) imidazo [1,2-a] pyrimidine, was synthesized by the following synthesis method.

Figure pat00014
Figure pat00014

1) 중간체 C-1의 합성1) Synthesis of intermediate C-1

250ml 3구 둥근바닥플라스크에 2-아미노피리미딘(5 g), 브로모아세트알데하이드 디에틸 아세탈(20.7 g), 48% 브롬산 수용액(5 ml), 에탄올(50 ml)을 넣고 18시간 동안 환류 교반하였다. 반응액을 상온으로 식힌 후 실리카겔 흡착하였다. 디클로로메탄과 메탄올을 이용한 컬럼 분리를 통하여 표제 화합물 5g을 얻었다.2-aminopyrimidine (5 g), bromoacetaldehyde diethyl acetal (20.7 g), 48% aqueous solution of bromic acid (5 ml) and ethanol (50 ml) were placed in a 250 ml three-neck round bottom flask, Lt; / RTI > The reaction solution was cooled to room temperature and adsorbed on silica gel. 5 g of the title compound was obtained by column separation using dichloromethane and methanol.

2) 중간체 C-2의 합성2) Synthesis of intermediate C-2

100ml 3구 둥근바닥플라스크에 화합물 C-1(4g), 아세트산나트륨 (4.3g)을 메탄올 (40ml)에 녹인 후 -10로 낮췄다. 브롬(5.38g)을 천천히 적가하였다. 1M 황화나트륨 수용액(40 ml)를 첨가한 후 감압 농축하였다. 부산물을 에틸아세테이트와 물로 추출하고 수분제거 후 생성된 물질에 대해 디클로로메탄과 메탄올을 이용한 컬럼 분리를 수행하여 표제 화합물 3.2g을 얻었다.Compound C-1 (4 g) and sodium acetate (4.3 g) were dissolved in methanol (40 ml) into a 100 ml three-necked round bottom flask and then cooled to -10. Bromine (5.38 g) was slowly added dropwise. 1 M aqueous sodium sulfide solution (40 ml) was added, and the mixture was concentrated under reduced pressure. The by-product was extracted with ethyl acetate and water, and the resulting material was subjected to column separation using dichloromethane and methanol to obtain 3.2 g of the title compound.

3) 중간체 C-3의 합성3) Synthesis of intermediate C-3

250ml 3구 둥근바닥플라스크에 화합물 C-2(4 g), 무수테트라히드로퓨란(120ml)을 첨가하고 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78로 낮추어 주었다. 2.9M 아이소프로필마그네슘브로마이드(7.6 ml)를 천천히 첨가한 후 1시간 동안 동일온도에서 교반하였다. 동일온도에서 트리부틸틴클로라이드(7.9g)를 투입하고 혼합액의 온도를 상온으로 승온한 후 12 시간 동안 교반하였다. 물을 첨가하고 유기층을 층분리하여 감압 농축하였다. 농축에 의해 생성된 물질에 대해 정제과정 없이 다음 반응을 진행하였다.Compound C-2 (4 g) and anhydrous tetrahydrofuran (120 ml) were added to a 250-ml three-neck round bottom flask, stirred under an argon atmosphere and the temperature of the mixture was lowered to -78. 2.9M isopropylmagnesium bromide (7.6 ml) was added slowly and stirred at the same temperature for 1 hour. Tributyltin chloride (7.9 g) was added at the same temperature, the temperature of the mixture was raised to room temperature, and the mixture was stirred for 12 hours. Water was added and the organic layer was separated and concentrated under reduced pressure. The following reaction was carried out without purification for the material produced by concentration.

4) 중간체 C-4의 합성4) Synthesis of intermediate C-4

100ml 3구 둥근바닥플라스크에 중간체 C-3(8 g), 2,6-디브로모피리딘(5.5 g), 톨루엔(60 ml)을 넣고 아르곤 분위기 하에서 교반하였다. 이 혼합액에 비스(트리페닐포스핀)팔라듐(II)디클로라이드(0.66 g)을 넣고 80로 가열하였다. 물을 첨가하고 반응액을 층 분리하여 물을 제거하고 유기층을 물로 2회 세척하였다. 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질에 대해 디클로로메탄을 이용한 컬럼 분리를 수행하여 표제 화합물 3g을 얻었다.Intermediate C-3 (8 g), 2,6-dibromopyridine (5.5 g) and toluene (60 ml) were placed in a 100 ml three-neck round bottom flask and stirred under argon atmosphere. Bis (triphenylphosphine) palladium (II) dichloride (0.66 g) was added to the mixture and the mixture was heated to 80 ° C. Water was added and the reaction mixture was layered to remove water, and the organic layer was washed twice with water. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure to remove the solvent. Columns separation using dichloromethane on the material produced by concentration yielded 3 g of the title compound.

(2) 화합물 1의 합성(2) Synthesis of Compound 1

250ml 3구 둥근바닥플라스크에 중간체 C-4(3 g), 카바졸(2.2 g), 톨루엔(60 ml)을 넣고 아르곤 분위기 하에서 교반하였다. 이 혼합액에 트리스디벤질리딘아세톤디팔라듐(0)(0.2 g), 트리-t-부틸포스핀(0.2 g), 소듐-t-부톡사이드(2.3 g)를 넣고 18시간 동안 교반 환류하였다. 반응이 종결된 후, 감압농축하고, 농축에 의해 생성된 물질에 대해 디클로로메탄을 이용한 컬럼 분리를 수행하여 표제 화합물 2.5g을 얻었다.Intermediate C-4 (3 g), carbazole (2.2 g) and toluene (60 ml) were placed in a 250 ml three-necked round bottom flask and stirred under argon atmosphere. To the mixture was added tris (dibenzylidine) acetone dipalladium (0) (0.2 g), tri-t-butylphosphine (0.2 g) and sodium-t-butoxide (2.3 g) and the mixture was stirred and refluxed for 18 hours. After the reaction was completed, the reaction mixture was concentrated under reduced pressure, and the resulting material was subjected to column separation using dichloromethane to obtain 2.5 g of the title compound.

실시예 2: 화합물 2의 제조Example 2: Preparation of compound 2

화합물 2는 다음의 합성 방법으로 합성하였다.Compound 2 was synthesized by the following synthesis method.

Figure pat00015
Figure pat00015

카바졸 대신에 9,9-디메틸-9,10-디히드로아크리딘을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 2를 수득하였다.Compound 2 was obtained in the same manner as in the synthesis of Compound 1, except that 9,9-dimethyl-9,10-dihydrothiocridine was added instead of carbazole.

실시예 3: 화합물 3의 제조Example 3: Preparation of Compound 3

화합물 3은 다음의 합성 방법으로 합성하였다.Compound 3 was synthesized by the following synthesis method.

Figure pat00016
Figure pat00016

카바졸 대신에 페노시아진을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 3을 수득하였다.Compound 3 was obtained in the same manner as in the synthesis of Compound 1, except that phenothiazine was added instead of carbazole.

실시예 4: 화합물 4의 합성Example 4: Synthesis of Compound 4

화합물 4는 다음의 합성 방법으로 합성하였다.Compound 4 was synthesized by the following synthesis method.

Figure pat00017
Figure pat00017

카바졸 대신에 페녹사진을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 4를 수득하였다.Compound 4 was obtained in the same manner as in the synthesis of Compound 1, except that phenoxazine was added instead of carbazole.

실시예 5: 화합물 5의 제조Example 5: Preparation of compound 5

중간체 1-3 대신에 중간체 5-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 5를 수득하였다. 중간체 5-3는 다음의 합성 방법으로 합성하였다.Compound 5 was obtained in the same manner as in the synthesis of Compound 1 except that Intermediate 5-3 was used instead of Intermediate 1-3. Intermediate 5-3 was synthesized by the following synthesis method.

Figure pat00018
Figure pat00018

중간체 5-1의 합성Synthesis of Intermediate 5-1

250ml 3구 둥근바닥플라스크에 3-아이오도카바졸(10g), 디메틸포름아마이드(25ml)를 넣고 교반하였다. 이 혼합액에 온도를 0로 유지한 후 수소화나트륨(1.22g)을 넣는다. 10분 후 파라염화톨루엔 설포닐(7.1g)을 넣고 4시간 교반하였다. 물을 첨가한 후 필터링을 하여 고상을 분리하였다. 디클로로메탄으로 재결정하여 표제 화합물 12g을 얻었다.3-Iodocarbazole (10 g) and dimethylformamide (25 ml) were added to a 250 ml three-neck round bottom flask and stirred. The temperature of the mixture is maintained at 0, and sodium hydride (1.22 g) is added. After 10 minutes, toluenesulfonyl chloride (7.1 g) was added thereto, followed by stirring for 4 hours. After addition of water, the solid phase was separated by filtering. Recrystallization from dichloromethane gave 12 g of the title compound.

중간체 5-2의 합성Synthesis of Intermediate 5-2

250ml 3구 둥근바닥플라스크에 중간체 5-1(12g), 카바졸(7g), 제1산화구리(8.98g), 디메틸포름아마이드(24ml)를 넣고 100에서 12시간 교반하였다. 상온에서 냉각 후 실리카 필터링을 하였다. 필터링한 용액을 감압농축 후 물과 메탄올로 씻어줬다. 수분제거 후 생성된 물질에 대해 헥산을 이용한 컬럼 분리를 수행하여 표제 화합물 12g을 얻었다.Intermediate 5-1 (12 g), carbazole (7 g), cuprous oxide (8.98 g) and dimethylformamide (24 ml) were placed in a 250 ml three-necked round bottom flask and stirred at 100 for 12 hours. After cooling at room temperature, the silica was filtered. The filtered solution was concentrated under reduced pressure and then washed with water and methanol. After the removal of water, the resulting material was subjected to column separation using hexane to obtain 12 g of the title compound.

중간체 5-3의 합성Synthesis of Intermediate 5-3

100ml 3구 둥근바닥플라스크에 중간체 5-2(12 g), 수산화칼륨(1.0g), 테트라히드로퓨란(36ml), 메탄올(18ml)을 넣고 상온에서 4시간 교반하였다. 실리카겔 필터링 후 감압농축을 하였다. 고상을 물로 씻은 후 디클로로에탄으로 재결정하여 표제 화합물 3g을 얻었다.Intermediate 5-2 (12 g), potassium hydroxide (1.0 g), tetrahydrofuran (36 ml) and methanol (18 ml) were added to a 100 ml three-necked round bottom flask and stirred at room temperature for 4 hours. After silica gel filtration, the filtrate was concentrated under reduced pressure. The solid phase was washed with water and then recrystallized from dichloroethane to obtain 3 g of the title compound.

실시예 6: 화합물 6의 제조Example 6: Preparation of compound 6

카바졸 대신에 9,9-디메틸-9,10-디히드로아크리딘를 첨가한 것을 제외하고는 실시예 5와 동일한 방법으로 중간체 6-3의 화합물 3.7g을 수득하였다.3.7 g of the compound of Intermediate 6-3 was obtained in the same manner as in Example 5, except that 9,9-dimethyl-9,10-dihydropyridine was used instead of carbazole.

Figure pat00019
Figure pat00019

중간체 1-3 대신에 중간체 6-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 6을 수득하였다.Compound 6 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 6-3 was used instead of Intermediate 1 -3.

실시예 7: 화합물 7의 제조Example 7: Preparation of Compound 7

카바졸 대신에 페노시아진을 첨가한 것을 제외하고는 실시예 5와 동일한 방법으로 중간체 7-3의 화합물 4g을 수득하였다.4 g of a compound of Intermediate 7-3 was obtained in the same manner as in Example 5, except that phenothiazine was added instead of carbazole.

Figure pat00020
Figure pat00020

중간체 1-3 대신에 중간체 7-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 7을 수득하였다.Compound 7 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 7-3 was used instead of Intermediate 1 -3.

실시예 8: 화합물 8의 제조Example 8: Preparation of compound 8

카바졸 대신에 페녹사진을 첨가한 것을 제외하고는 실시예 5와 동일한 방법으로 중간체 8-3의 화합물 3.5g을 수득하였다. 3.5 g of the compound of Intermediate 8-3 was obtained in the same manner as in Example 5, except that phenoxazine was used instead of carbazole.

Figure pat00021
Figure pat00021

중간체 1-3 대신에 중간체 8-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 8을 수득하였다.Compound 8 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 8-3 was used instead of Intermediate 1-3.

실시예 9: 화합물 9의 제조Example 9: Preparation of Compound 9

중간체 1-3 대신에 중간체 9-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 9를 수득하였다. 중간체 9-3는 다음의 합성 방법으로 합성하였다Compound 9 was obtained in the same manner as in the synthesis of Compound 1 except that Intermediate 9-3 was used instead of Intermediate 1 -3. Intermediate 9-3 was synthesized by the following synthesis method

Figure pat00022
Figure pat00022

중간체 9-1의 합성Synthesis of intermediate 9-1

250ml 3구 둥근바닥플라스크에 브로모아이오도벤젠 (20g), 아닐린 (6.58g)을 넣고 교반하였다. 이 혼합액에 소듐-t-부톡사이드(9.51g), 2',4',6'-트리아이소프로필비페닐-2-디사이클로헥실포스핀(0.82g), 트리스디벤질리딘아세톤디팔라듐(0)을 넣고 온도를 80 로 유지하였다. 12시간 후 상온에서 냉각 후 디클로로메탄으로 실리카겔 필터링 후 감압농축하여 표제 화합물 16g을 얻었다.Bromoiodobenzene (20 g) and aniline (6.58 g) were placed in a 250 ml three-necked round bottom flask and stirred. To this mixture was added sodium-t-butoxide (9.51 g), 2 ', 4', 6'-triisopropylbiphenyl-2-dicyclohexylphosphine (0.82 g), trisdibenzylidineacetone dipalladium ) Was added and the temperature was maintained at 80. After 12 hours, the reaction mixture was cooled to room temperature, filtered through silica gel with dichloromethane, and concentrated under reduced pressure to obtain 16 g of the title compound.

중간체 9-2의 합성Synthesis of intermediate 9-2

진공 건조한 250ml 3구 둥근바닥플라스크에 화합물 9-1(16g), 무수테트라히드로퓨란(120ml)을 첨가하고 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78로 낮추어 주었다. 부틸리튬(56.75ml)를 천천히 첨가한 후 1시간 동안 동일온도에서 교반하였다. 동일온도에서 산톤(15.18g)을 넣고 12시간 동안 교반하였다. 감압농축 후 클로로포름(320ml)으로 추출하여 표제 화합물 8g을 얻었다. Compound 9-1 (16 g) and anhydrous tetrahydrofuran (120 ml) were added to a vacuum-dried 250 ml three-neck round bottom flask, and stirred under argon atmosphere, and the temperature of the mixture was lowered to -78. Butyllithium (56.75 ml) was added slowly and stirred at the same temperature for 1 hour. At the same temperature, thionate (15.18 g) was added and stirred for 12 hours. After concentration under reduced pressure, the residue was extracted with chloroform (320 ml) to obtain 8 g of the title compound.

중간체 9-3의 합성Synthesis of intermediate 9-3

250ml 3구 둥근바닥플라스크에 추출한 화합물 9-2(8g), 클로로포름(100ml), 메탄설포닉 산(6.82g) 을 넣고 60로 유지하였다. 탄산수소나트륨 수용액을 천천히 넣고 교반하였다. 클로로포름을 여러번 추출하였다. 클로로포름과 메탄올로 고체를 필터링하여 표제 화합물 3.1g을 얻었다.Compound 9-2 (8 g), chloroform (100 ml) and methanesulfonic acid (6.82 g) extracted into a 250 ml three-necked round bottom flask were added and kept at 60 ° C. Sodium bicarbonate aqueous solution was slowly added and stirred. Chloroform was extracted several times. The solid was filtered off with chloroform and methanol to obtain 3.1 g of the title compound.

실시예 10: 화합물 10의 제조Example 10: Preparation of compound 10

중간체 1-3 대신에 중간체 10-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 10을 수득하였다. 중간체 10-3은 다음의 합성 방법으로 합성하였다.Compound 10 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 10-3 was used instead of Intermediate 1 -3. Intermediate 10-3 was synthesized by the following synthesis method.

Figure pat00023
Figure pat00023

중간체 10-1의 합성Synthesis of Intermediate 10-1

250ml 3구 둥근바닥플라스크에 2-브로모카바졸(10g), 디메틸포름아마이드(25ml)를 넣고 교반하였다. 이 혼합액에 온도를 0로 유지한 후 수소화나트륨(1.22g)을 첨가하였다. 10분 후 파라염화톨루엔 설포닐(7.1g)을 넣고 4시간 교반하였다. 물을 첨가한 후 필터링하여 고상을 분리하였다. 디클로로메탄으로 재결정하여 표제 화합물 12g을 얻었다.2-bromocarbazole (10 g) and dimethylformamide (25 ml) were added to a 250 ml three-neck round bottom flask and stirred. The temperature of the mixture was maintained at 0, and sodium hydride (1.22 g) was added. After 10 minutes, toluenesulfonyl chloride (7.1 g) was added thereto, followed by stirring for 4 hours. After adding water, the solid phase was separated by filtering. Recrystallization from dichloromethane gave 12 g of the title compound.

중간체 10-2의 합성Synthesis of Intermediate 10-2

250ml 3구 둥근바닥플라스크에 화합물 10-1(12g), 카바졸(7g), 제1산화구리(8.98g), 디메틸포름아마이드(24ml)를 넣고 100 에서 12시간 교반하였다. 상온에서 냉각 후 실리카 필터링을 하였다. 필터한 용액을 감압농축 후 물과 메탄올로 씻어줬다. 수분제거 후 생성된 물질에 대해 헥산을 이용한 컬럼 분리를 수행하여 표제 화합물 12g을 얻었다.Compound 10-1 (12 g), carbazole (7 g), cuprous oxide (8.98 g) and dimethylformamide (24 ml) were placed in a 250 ml three-necked round bottom flask and stirred at 100 for 12 hours. After cooling at room temperature, the silica was filtered. The filtered solution was concentrated under reduced pressure and washed with water and methanol. After the removal of water, the resulting material was subjected to column separation using hexane to obtain 12 g of the title compound.

중간체 10-3의 합성Synthesis of intermediate 10-3

100ml 3구 둥근바닥플라스크에 화합물 10-2(12g), 수산화칼륨(1.0g), 테트라히드로퓨란(36ml), 메탄올(18ml)를 넣고 상온에서 4시간 교반하였다. 실리카겔 필터링 후 감압농축을 하고, 고상을 물로 씻은 후 디클로로메탄으로 재결정하여 표제 화합물 3.6g을 얻었다.Compound 10-2 (12 g), potassium hydroxide (1.0 g), tetrahydrofuran (36 ml) and methanol (18 ml) were added to a 100 ml three-necked round bottom flask and stirred at room temperature for 4 hours. The filtrate was concentrated under reduced pressure, and the solid phase was washed with water and then recrystallized from dichloromethane to obtain 3.6 g of the title compound.

실시예 11: 화합물 11의 제조Example 11: Preparation of compound 11

카바졸 대신에 9,9-디메틸-9,10-디히드로아크리딘을 첨가한 것을 제외하고는 실시예 10과 동일한 방법으로 중간체 11-3의 화합물 3.6g을 수득하였다. 3.6 g of the compound of Intermediate 11-3 was obtained in the same manner as in Example 10, except that 9,9-dimethyl-9,10-dihydraacridine was added instead of carbazole.

Figure pat00024
Figure pat00024

중간체 1-3 대신에 중간체 11-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 11을 수득하였다.Compound 11 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 11-3 was used instead of Intermediate 1-3.

실시예 12: 화합물 12의 제조Example 12: Preparation of Compound 12

카바졸 대신에 페노시아진을 첨가한 것을 제외하고는 실시예 10과 동일한 방법으로 중간체 12-3의 화합물 3.5g을 수득하였다. 3.5 g of the compound of Intermediate 12-3 was obtained in the same manner as in Example 10 except that phenothiazine was added instead of carbazole.

Figure pat00025
Figure pat00025

중간체 1-3 대신에 중간체 12-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 12를 수득하였다.Compound 12 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 12-3 was used instead of Intermediate 1 -3.

실시예 13: 화합물 13의 제조Example 13: Preparation of compound 13

카바졸 대신에 페녹사진을 첨가한 것을 제외하고는 실시예 10과 동일한 방법으로 중간체 13-3의 화합물 3.2g을 수득하였다. 3.2 g of the compound of Intermediate 13-3 was obtained in the same manner as in Example 10 except that phenoxazine was added instead of carbazole.

Figure pat00026
Figure pat00026

중간체 1-3 대신에 중간체 13-3을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 13을 수득하였다.Compound 13 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 13-3 was used instead of Intermediate 1-3.

실시예 14: 화합물 14의 제조Example 14: Preparation of compound 14

중간체 1-3 대신에 중간체 14-4를 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 14를 수득하였다. 중간체 14-4는 다음의 합성 방법으로 합성하였다.Compound 14 was obtained in the same manner as in the synthesis of Compound 1 except that Intermediate 14-4 was used instead of Intermediate 1 -3. Intermediate 14-4 was synthesized by the following synthesis method.

Figure pat00027
Figure pat00027

Figure pat00028
Figure pat00028

중간체 14-1의 합성Synthesis of Intermediate 14-1

250ml 3구 둥근바닥플라스크에 3-브로모카바졸(10g), 페닐보로닉에시드(7.4g), 테트라히드로퓨란(200ml), 탄산칼륨(16.8g) 및 물(60ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스틴)팔라듐(0)(0.95g)을 넣고 80로 가열하였다. 반응액을 층 분리하여 물을 제거하고 유기층을 물로 2회 세척하였다. 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질에 대해 헥산을 이용한 컬럼 분리를 수행하여 표제 화합물 7.1g을 얻었다.3-bromocarbazole (10 g), phenylboronic acid (7.4 g), tetrahydrofuran (200 ml), potassium carbonate (16.8 g) and water (60 ml) were added to a 250 ml three-necked round bottom flask and stirred. Tetrakis (triphenylphosphine) palladium (0) (0.95 g) was added to the mixture, and the mixture was heated to 80 ° C. The reaction solution was layered to remove water, and the organic layer was washed twice with water. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure to remove the solvent. Columns separation using hexane was performed on the material formed by concentration to obtain 7.1 g of the title compound.

중간체 14-2의 합성Synthesis of Intermediate 14-2

1000ml 3구 둥근바닥플라스크에 디메틸포름아마이드(600ml)를 넣고 0에서 교반하였다. 수소화나트륨(2.6g)을 천천히 넣고, 2-브로모카바졸 (10g)을 천천히 적하시켰다. 이 혼합액을 5분간 교반 후 파라염화톨루엔-설포닐을 천천히 적하한 후 4시간 교반하였다. 물을 첨가한 후 필터링을 하여 고상을 분리한 후 디클로로메탄으로 재결정하여 표제 화합물 7.6g을 얻었다.Dimethylformamide (600 ml) was added to a 1000 ml three-neck round bottom flask and stirred at 0 ° C. Sodium hydride (2.6 g) was slowly added, and 2-bromocarbazole (10 g) was slowly added dropwise. After the mixture was stirred for 5 minutes, toluene-sulfonyl para-chloride was slowly added dropwise, followed by stirring for 4 hours. After addition of water, the solid was separated by filtering, and recrystallized from dichloromethane to obtain 7.6 g of the title compound.

중간체 14-3의 합성Synthesis of Intermediate 14-3

250ml 3구 둥근바닥플라스크에 화합물 14-1(6.9g), 중간체 14-2(7.6g), 제1산화구리(5.4g), 디메틸포름아마이드(20ml)를 넣고, 100에서 12시간 교반하였다. 상온에서 냉각 후 실리카겔 필터링을 하였다. 필터링한 용액을 감압농축 후 물과 메탄올로 씻어줬다. 수분제거 후 생성된 물질에 대해 헥산을 이용한 컬럼 분리를 수행하여 표제 화합물 5.3g을 얻었다.Compound 14-1 (6.9 g), intermediate 14-2 (7.6 g), cuprous oxide (5.4 g) and dimethylformamide (20 ml) were placed in a 250 ml three-necked round bottom flask and stirred at 100 for 12 hours. After cooling at room temperature, silica gel filtration was performed. The filtered solution was concentrated under reduced pressure and then washed with water and methanol. After the removal of water, the resulting material was subjected to column separation using hexane to obtain 5.3 g of the title compound.

중간체 14-4의 합성Synthesis of Intermediate 14-4

100ml 3구 둥근바닥플라스크에 화합물 14-3(5.3 g), 수산화칼륨(0.46g), 테트라히드로퓨란(16ml), 메탄올(8ml)을 넣고 상온에서 4시간 교반하였다. 실리카필터링 후 감압농축하고, 고체를 물로 씻은 후 디클로로로메탄으로 재결정하여 표제 화합물 3g을 얻었다.Compound 13-3 (5.3 g), potassium hydroxide (0.46 g), tetrahydrofuran (16 ml) and methanol (8 ml) were added to a 100 ml three-necked round bottom flask and stirred at room temperature for 4 hours. After silica filtration, the filtrate was concentrated under reduced pressure. The solid was washed with water and recrystallized from dichloromethane to obtain 3 g of the title compound.

실시예 15: 화합물 15의 제조Example 15: Preparation of compound 15

3-브로모카바졸 대신에 3,6-디브로모카바졸을 첨가한 것을 제외하고는 중간체 14-4의 합성법과 동일한 방법으로 중간체 15-4의 화합물 5g을 얻었다.5 g of the compound of Intermediate 15-4 was obtained in the same manner as in the synthesis of Intermediate 14-4, except that 3,6-dibromocarbazole was added instead of 3-bromocarbazole.

Figure pat00029
Figure pat00029

Figure pat00030
Figure pat00030

중간체 1-3 대신에 중간체 15-4를 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 15를 수득하였다.Compound 15 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 15-4 was used instead of Intermediate 1-3.

실시예 16: 화합물 18의 제조Example 16: Preparation of compound 18

중간체 1-3 대신에 중간체 18-1을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 18을 수득하였다. 중간체 18-1은 다음의 합성 방법으로 합성하였다.Compound 18 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 18-1 was used instead of Intermediate 1-3. Intermediate 18-1 was synthesized by the following synthesis method.

Figure pat00031
Figure pat00031

250ml 3구 둥근바닥플라스크에 3-브로모카바졸(3 g), 디벤조 퓨란 4-보로닉에시드(3.1 g), 테트라히드로퓨란(60 ml), 탄산칼륨(8.4g) 및 물 (60ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스틴)팔라듐(0)(0.4g)을 넣고 80로 가열하였다. 반응액을 층 분리하여 물을 제거하고 유기층을 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질에 대해 컬럼 분리를 수행하여 표제 화합물 3g을 얻었다.3-bromocarbazole (3 g), dibenzofuran 4-boronic acid (3.1 g), tetrahydrofuran (60 ml), potassium carbonate (8.4 g) and water (60 ml) were added to a 250 ml three- And stirred. Tetrakis (triphenylphosphine) palladium (0) (0.4 g) was added to the mixture and the mixture was heated to 80 ° C. The reaction solution was layered to remove water, and the organic layer was concentrated under reduced pressure to remove the solvent. Column separation was performed on the material produced by concentration to obtain 3 g of the title compound.

실시예 17: 화합물 20의 제조Example 17: Preparation of compound 20

중간체 1-3 대신에 중간체 20-1을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 20을 수득하였다. 중간체 20-1은 다음의 합성 방법으로 합성하였다.Compound 20 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 20-1 was used instead of Intermediate 1-3. Intermediate 20-1 was synthesized by the following synthesis method.

Figure pat00032
Figure pat00032

디벤조 퓨란 4-보로닉에시드 대신에 디벤조 싸이오펜 2-보로닉에시드를 첨가한 것을 제외하고는 중간체 18-1의 합성법과 동일한 방법으로 표제 화합물 3g 을 수득하였다.Dibenzofuran 3g of the title compound was obtained in the same manner as in the synthesis of Intermediate 18-1, except that dibenzothiophene 2-boronic acid was added instead of 4-boronic acid.

실시예 18: 화합물 22의 제조Example 18: Preparation of Compound 22

중간체 1-3 대신에 중간체 22-1을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 22를 수득하였다. 중간체 22-1은 다음의 합성 방법으로 합성하였다.Compound 22 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 22-1 was used instead of Intermediate 1-3. Intermediate 22-1 was synthesized by the following synthesis method.

Figure pat00033
Figure pat00033

250ml 3구 둥근바닥플라스크에 2-브로모카바졸(3 g), 디벤조 퓨란 4-보로닉에시드(3.1 g), 테트라히드로퓨란(60 ml), 탄산칼륨(8.4g) 및 물 (60ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스틴)팔라듐(0)(0.4g)을 넣고 80로 가열하였다. 반응액을 층 분리하여 물을 제거하고 유기층을 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질에 대해 컬럼 분리를 수행하여 표제 화합물 3g을 얻었다.(3 g), dibenzofuran 4-boronic acid (3.1 g), tetrahydrofuran (60 ml), potassium carbonate (8.4 g) and water (60 ml) were added to a 250 ml three- And stirred. Tetrakis (triphenylphosphine) palladium (0) (0.4 g) was added to the mixture and the mixture was heated to 80 ° C. The reaction solution was layered to remove water, and the organic layer was concentrated under reduced pressure to remove the solvent. Column separation was performed on the material produced by concentration to obtain 3 g of the title compound.

실시예 19: 화합물 24의 제조Example 19: Preparation of Compound 24

중간체 1-3 대신에 중간체 24-1을 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 24를 수득하였다. 중간체 24-1은 다음의 합성 방법으로 합성하였다.Compound 24 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 24-1 was used instead of Intermediate 1-3. Intermediate 24-1 was synthesized by the following synthesis method.

Figure pat00034
Figure pat00034

디벤조 퓨란 4-보로닉에시드 대신에 디벤조 퓨란 2-보로닉에시드를 첨가한 것을 제외하고는 중간체 22-1의 합성법과 동일한 방법으로 표제 화합물 3g 을 수득하였다.3-g of the title compound was obtained in the same manner as in the synthesis of Intermediate 22-1, except that dibenzofuran-2-boronic acid was added instead of dibenzofuran-4-boronic acid.

실시예 20: 화합물 31의 제조Example 20: Preparation of compound 31

중간체 1-3 대신에 중간체 31-2를 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 31을 수득하였다. 중간체 31-2는 다음의 합성 방법으로 합성하였다.Compound 31 was obtained in the same manner as in the synthesis of Compound 1 except that Intermediate 31-2 was used instead of Intermediate 1 -3. Intermediate 31-2 was synthesized by the following synthesis method.

Figure pat00035
Figure pat00035

중간체 31-1의 합성Synthesis of Intermediate 31-1

250 ml 3구 둥근바닥플라스크에 4-디벤조사이오펜-보로닉 에시드(10 g), 1-브로모-2-나이트로벤젠(11.8 g), 톨루엔(100 ml), 에탄올(20 ml), 탄산칼륨(12.1 g) 및 물(20 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스틴)팔라듐(0)(1.5 g)을 넣고 80로 가열하였다. 반응액을 층 분리하여 물을 제거하고 유기층을 물로 2회 세척하였다. 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질에 대해 디클로로메탄 및 헥산 혼합용매를 이용한 컬럼 분리를 수행하여 표제 화합물 11.3 g을 얻었다.4-dibenzothiophene-boronic acid (10 g), 1-bromo-2-nitrobenzene (11.8 g), toluene (100 ml) and ethanol (20 ml) were added to a 250 ml three- Potassium carbonate (12.1 g) and water (20 ml) were added and stirred. Tetrakis (triphenylphosphine) palladium (0) (1.5 g) was added to the mixture and the mixture was heated to 80 ° C. The reaction solution was layered to remove water, and the organic layer was washed twice with water. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure to remove the solvent. Column separation using a dichloromethane and hexane mixed solvent was performed on the substance produced by concentration to obtain 11.3 g of the title compound.

중간체 31-2의 합성Synthesis of intermediate 31-2

250 ml 3구 둥근바닥플라스크에 화합물 31-1(8 g), 트리페닐포스핀(20.6 g), 1,3-디클로로벤젠(56 ml)을 넣고 환류하며 12시간 교반하였다. 감압농축하여 용매를 제거하였다. 농축에 의해 생성된 물질에 대해 디클로로메탄 및 헥산 혼합용매를 이용한 컬럼 분리를 수행하여 표제 화합물 6 g을 얻었다.Compound 31-1 (8 g), triphenylphosphine (20.6 g) and 1,3-dichlorobenzene (56 ml) were placed in a 250 ml three-necked round bottom flask, and the mixture was refluxed and stirred for 12 hours. The solvent was removed by concentration under reduced pressure. Column separation using a dichloromethane and hexane mixed solvent was performed on the substance produced by concentration to obtain 6 g of the title compound.

실시예 21: 화합물 33의 제조Example 21: Preparation of compound 33

중간체 1-3 대신에 중간체 33-2를 첨가한 것을 제외하고는 화합물 1의 합성법과 동일한 방법으로 화합물 33을 수득하였다. 중간체 33-2는 다음의 합성 방법으로 합성하였다.Compound 33 was obtained in the same manner as in the synthesis of Compound 1, except that Intermediate 33-2 was used instead of Intermediate 1 -3. Intermediate 33-2 was synthesized by the following synthesis method.

Figure pat00036
Figure pat00036

중간체 33-1의 합성Synthesis of Intermediate 33-1

1L 3구 둥근바닥플라스크에 2-브로모-(9-페닐-카바졸)(20 g), 2-클로로아닐린(9.5 g), 톨루엔(400 ml)을 넣고 아르곤 분위기 하에서 교반하였다. 이 혼합액에 트리스디벤질리딘아세톤디팔라듐(0) (0.8 g), 트리-t-부틸포스핀(0.8 g), 소듐-t-부톡사이드(8.9 g)를 넣고 5시간 동안 교반 환류하였다. 반응액을 물과 에틸아세테이트로 층분리하여 유기층을 감압농축 하였다. 농축에 의해 생성된 물질에 대해 디클로로메탄 및 헥산 혼합용매를 이용한 컬럼 분리를 수행하여 표제 화합물 17 g을 얻었다.2-Bromo- (9-phenyl-carbazole) (20 g), 2-chloroaniline (9.5 g) and toluene (400 ml) were placed in a 1 L three-necked round bottom flask and stirred under argon atmosphere. Tris-dibenzylidineacetone dipalladium (0) (0.8 g), tri-t-butylphosphine (0.8 g) and sodium-t-butoxide (8.9 g) were added to the mixed solution, and the mixture was refluxed with stirring for 5 hours. The reaction solution was separated into water and ethyl acetate, and the organic layer was concentrated under reduced pressure. Column separation using a mixed solvent of dichloromethane and hexane was carried out on the substance produced by concentration to obtain 17 g of the title compound.

중간체 33-2의 합성Synthesis of intermediate 33-2

500 ml 3구 둥근바닥플라스크에 중간체 33-1(12.5 g), 팔라듐() 아세테이트(0.38 g), 트리사이클로헥실포스핀 테트라플루오로보레이트 (1.25 g), 세슘카보네이트(33.1 g), 디메틸아세트아마이드(180 ml)를 넣고 190에서 5 시간 동안 교반한 다음 냉각하였다. 반응액을 물과 에틸아세테이트로 층분리 하여 유기층을 감압농축하였다. 농축에 의해 생성된 물질에 대해 디클로로메탄 및 헥산 혼합용매를 이용한 컬럼 분리를 수행하여 표제 화합물 5 g을 얻었다.To a 500 ml 3-necked round bottom flask were added intermediate 33-1 (12.5 g), palladium (.) Acetate (0.38 g), tricyclohexylphosphine tetrafluoroborate (1.25 g), cesium carbonate (33.1 g), dimethylacetamide (180 ml) was added and the mixture was stirred at 190 for 5 hours and then cooled. The reaction solution was separated into water and ethyl acetate, and the organic layer was concentrated under reduced pressure. Columns separation using dichloromethane and hexane mixed solvent was performed on the substance produced by concentration to obtain 5 g of the title compound.

실시예 1 내지 33에서 제조한 각각의 화합물의 구조식과 NMR 데이터를 하기 표 1에 나타내었다.Structural formulas and NMR data of the respective compounds prepared in Examples 1 to 33 are shown in Table 1 below.

화합물compound 구조식constitutional formula 1H NMR (500 MHz, CDCl3, TMS) δ(PPM) 1 H NMR (500 MHz, CDCl 3, TMS) δ (PPM) 1One

Figure pat00037
Figure pat00037
8.84-8.82(dd,1H), 8.79-8.77(dd,1H), 8.56-8.53(dd,1H), 8.41-8.40(dd, 1H), 8.12-8.10(dd, 1H), 7.94-7.86(m,2H), 7.72-7.63(m,2H),7.51-7.49(m,2H), 7.33-7.22(m, 4H)(Dd, 1H), 8.94-8.77 (dd, 1H), 8.56-8.53 (dd, 1H), 8.41-8.40 2H), 7.72-7.63 (m, 2H), 7.51-7.49 (m, 2H), 7.33-7.22 (m, 4H) 22
Figure pat00038
Figure pat00038
8.83-8.80(dd,1H), 8.78-8.77(dd,1H), 7.62-7.60(dd,1H), 7.51(s,1H), 7.41-7.39(m,1H), 7.28-7.26(dd,1H), 7.05-7.02(m,4H), 6.73-6.66(m,3H), 6.55-6.51(dd,2H), 1.72(s,6H)1H), 7.51 (s, 1H), 7.41-7.39 (m, 1H), 7.28-7.26 (dd, 1H), 8.83-8.80 (dd, 1H), 8.78-8.77 ), 7.05-7.02 (m, 4H), 6.73-6.66 (m, 3H), 6.55-6.51 (dd, 2H), 1.72
33
Figure pat00039
Figure pat00039
8.83-8.81(dd,1H), 8.79-8.77(dd,1H), 7.62-7.60(dd,1H), 7.52(s,1H), 7.41-7.39(m,1H), 7.28-7.24(m,3H),7.20-7.16(m,4H), 6.99-6.96(dd,2H), 6.66-6.64(dd,1H)(Dd, 1H), 7.62-7.60 (m, 3H) ), 7.20-7.16 (m, 4H), 6.99-6.96 (dd, 2H), 6.66-6.64 (dd,
44
Figure pat00040
Figure pat00040
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 7.63-7.61(dd,1H), 7.54(s,1H), 7.41-7.39(m,1H), 7.28-7.24(m,3H),7.21-7.17(m,4H), 6.98-6.96(dd,2H), 6.68-6.66(dd,1H)1H), 7.41-7.39 (m, 1H), 7.28-7.24 (m, 3H), 7.82-7.40 (dd, ), 7.21-7.17 (m, 4H), 6.98-6.96 (dd, 2H), 6.68-6.66 (dd,
55
Figure pat00041
Figure pat00041
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.57-8.55(dd,2H), 8.43-8.41(dd,1H), 8.14-8.12(dd,1H), 7.98-7.86(m,4H), 7.64-7.62(dd,2H), 7.77(dd,1H), 7.51-7.50(m,2H), 7.33-7.25(m,7H) (Dd, 1H), 8.78-8.76 (dd, 1H), 8.57-8.55 (dd, 2H), 8.43-8.41 2H), 7.33-7.25 (m, 7H), 7.60 (dd,
66
Figure pat00042
Figure pat00042
8.83-8.80(dd,1H), 8.78-8.77(dd,1H), 8.55-8.54(dd,1H), 8.41-8.39(dd,1H), 7.94-7.92(dd,1H), 7.86-7.84(dd,1H), 7.73-7.71(dd,1H), 7.51(s,1H), 7.33-7.28(m,4H), 7.05-7.02(m,4H), 7.77-7.73(m,4H), 6.55-6.53(dd,2H). 1.73(s,6H)(Dd, 1H), 8.86-8.77 (dd, 1H), 8.55-8.54 (dd, 1H), 8.41-8.39 (dd, 1H), 7.94-7.92 (M, 4H), 7.77-7.73 (m, 4H), 6.55-6.53 (m, 4H) (dd, 2H). 1.73 (s, 6 H)
77
Figure pat00043
Figure pat00043
8.82-8.80(dd,1H), 8.77-8.75(dd,1H), 8.55-8.54(dd,1H), 8.41-8.39(dd,1H), 7.96-7.94(dd,1H), 7.87-7.85(dd,1H), 7.73-7.71(dd,1H), 7.52(s,1H), 7.38-7.27(m,4H), 7.25-7.16(m,6H), 6.97-6.95(dd,2H), 6.77-6.75(dd,2H)(Dd, 1H), 8.87-8.75 (dd, 1H), 8.55-8.54 (dd, 1H), 8.41-8.39 2H), 6.77-6.75 (m, 4H), 7.25-7.16 (m, 6H), 6.97-6.95 (dd, (dd, 2H)
88
Figure pat00044
Figure pat00044
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.55-8.53(dd,1H), 8.41-8.39(dd,1H), 7.97-7.95(dd,1H), 7.87-7.85(dd,1H), 7.74-7.72(dd,1H), 7.51(s,1H), 7.38-7.27(m,4H), 7.25-7.16(m,6H), 6.96-6.94(dd,2H), 6.76-6.74(dd,2H)(Dd, 1H), 8.87-8.76 (dd, 1H), 8.55-8.53 (dd, 1H), 8.41-8.39 (dd, 1H), 7.97-7.95 (M, 6H), 6.96-6.94 (dd, 2H), 6.76-6.74 (m, 4H), 7.74-7.72 (dd, 2H)
99
Figure pat00045
Figure pat00045
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 7.64-7.62(dd,1H), 7.51(s,1H), 7.42-7.40(dd,1H), 7.28-7.19(m,7H), 7.05-6.98(m,6H), 6.66-6.60(m,3H), 6.51-6.49(dd,2H)(Dd, IH), 7.64-7.62 (dd, IH), 7.51 (s, IH), 7.42-7.40 (dd, IH), 7.28-7.19 ), 7.05-6.98 (m, 6H), 6.66-6.60 (m, 3H), 6.51-6.49 (dd, 2H)
1010
Figure pat00046
Figure pat00046
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,2H), 8.40-8.38(dd,1H), 8.12-8.10(dd,2H), 7.94-7.83(m,4H), 7.72-7.70(dd,1H), 7.63-7.61(dd,1H), 7.51-7.49(m,2H), 7.33-7.25(m,7H)(Dd, 1H), 8.78-8.76 (dd, 1H), 8.55-8.52 (dd, 2H), 8.40-8.38 2H), 7.33-7.25 (m, 7H), 7.72-7.70 (dd,
1111
Figure pat00047
Figure pat00047
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 8.03-8.01(dd,1H), 7.94-7.92(dd,1H), 7.86-7.84(dd,1H), 7.72-7.70(dd,1H), 7.51(s,1H), 7.33-7.25(m,3H), 7.05-7.02(m,4H), 6.73-6.67(m,4H), 6.65-6.62(dd,2H), 1.75(s,6H)(Dd, 1H), 8.84-8.76 (dd, 1H), 8.55-8.52 (dd, 1H), 8.40-8.38 1H), 7.86-7.84 (dd, 1H), 7.72-7.70 (m, 4H), 6.73-6.67 (m, 4H), 6.65-6.62 (dd, 2H), 1.75 (s, 6H)
1212
Figure pat00048
Figure pat00048
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 8.03-8.01(dd,1H), 7.94-7.92(dd,1H), 7.86-7.84(dd,1H), 7.72-7.70(dd,1H), 7.51(s,1H), 7.33-7.25(m,3H), 7.05-7.02(m,4H), 6.73-6.67(m,4H), 6.65-6.62(dd,2H)(Dd, 1H), 8.84-8.76 (dd, 1H), 8.55-8.52 (dd, 1H), 8.40-8.38 1H), 7.86-7.84 (dd, 1H), 7.72-7.70 (m, 4H), 6.73-6.67 (m, 4 H), 6.65 - 6.62 (dd, 2 H)
1313
Figure pat00049
Figure pat00049
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.53-8.51(dd,1H), 8.40-8.38(dd,1H), 8.01-7.99(dd,1H), 7.94-7.92(dd,1H), 7.86-7.84(dd,1H), 7.70-7.68(dd,1H), 7.49(s,1H), 7.33-7.24(m,3H), 7.05-7.02(m,4H), 6.73-6.67(m,4H), 6.63-6.61(dd,2H)(Dd, 1H), 8.83-8.76 (dd, 1H), 8.83-8.76 (dd, 1H), 8.53-8.51 (D, 1H), 7.86-7.84 (dd, 1H), 7.70-7.68 (dd, IH), 7.49 (s, IH), 7.33-7.24 (m, 3H), 7.05-7.02 (m, 4 H), 6.63 - 6.61 (dd, 2 H)
1414
Figure pat00050
Figure pat00050
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.53-8.51(dd,2H), 8.40-8.38(dd,1H), 8.12(dd,1H),7.94-7.92(dd,2H), 7.86-7.83(m,3H), 7.77-7.69(m,3H), 7.51(s,1H), 7.48-7.41(m,4H), 7.38-7.25(m,7H)2H), 8.40-8.38 (dd, 1H), 8.12 (dd, 1H), 7.94-7.92 (dd, 2H), 8.82-8.80 (dd, 1H), 8.78-8.76 ), 7.86-7.83 (m, 3H), 7.77-7.69 (m, 3H), 7.51 (s, 1H), 7.48-7. 41 (m, 4H), 7.38-7.25
1515
Figure pat00051
Figure pat00051
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.55-8.53(dd,1H), 8.40-8.38(dd,1H), 8.18-8.16(dd,1H), 8.12-8.10(dd,1H), 7.94-7.83(m, 5H), 7.77-7.69(m,4H), 7.53(m,1H), 7.52-7.41(m,10H), 7.33-7.21(m,4H)(Dd, 1H), 8.8-8.76 (dd, 1H), 8.55-8.53 (dd, 1H), 8.40-8.38 1H), 7.94-7.83 (m, 5H), 7.77-7.69 (m, 4H), 7.53
1616
Figure pat00052
Figure pat00052
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.53(dd,1H), 8.41-8.38(dd,1H), 8.18-8.16(dd,1H), 8.12-8.10(dd,1H), 7.94-7.83(m, 5H), 7.77-7.70(m,4H), 7.56(m,1H), 7.53-7.43(m,10H), 7.35-7.23(m,4H)(Dd, 1H), 8,88-8,76 (dd, 1H), 8.55-8.53 (dd, 1H), 8.41-8.38 1H), 7.94-7.83 (m, 5H), 7.77-7.70 (m, 4H), 7.56 (m,
1717
Figure pat00053
Figure pat00053
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.53-8.51(dd,2H), 8.40-8.38(dd,1H), 8.12(dd,1H),7.94-7.92(dd,2H), 7.86-7.83(m,3H), 7.77-7.69(m,3H), 7.51(s,1H), 7.48-7.43(m,4H), 7.40-7.27(m,7H)2H), 8.40-8.38 (dd, 1H), 8.12 (dd, 1H), 7.94-7.92 (dd, 2H), 8.82-8.80 (dd, 1H), 8.78-8.76 ), 7.86-7.83 (m, 3H), 7.77-7.69 (m, 3H), 7.51 (s, 1H), 7.48-7.43 (m, 4H), 7.40-7.27
1818
Figure pat00054
Figure pat00054
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 7.94-7.92(dd,1H), 7.90-7.83(m,4H), 7.76-7.72(m,3H), 7.70-7.66(m,2H), 7.51-7.49(s,1H), 7.36-7.25(m,6H)(Dd, 1 H), 7.90-7.83 (dd, 1 H), 7.85-8. 2H), 7.51-7.49 (s, IH), 7.36-7. 25 (m, 6H)
1919
Figure pat00055
Figure pat00055
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 7.92-7.90(dd,1H), 7.88-7.81(m,4H), 7.75-7.71(m,3H), 7.70-7.66(m,2H), 7.51-7.49(s,1H), 7.38-7.26(m,6H)(Dd, 1H), 8.78-8.76 (dd, 1H), 8.55-8.52 (dd, 1H), 8.40-8.38 (dd, 1H), 7.92-7.90 2H), 7.51-7.49 (s, IH), 7.38-7.26 (m, 6H)
2020
Figure pat00056
Figure pat00056
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 7.94-7.92(dd,1H), 7.90-7.84(m,4H), 7.74-7.70(m,3H), 7.70-7.66(m,2H), 7.51-7.49(s,1H), 7.36-7.26(m,6H)(Dd, 1 H), 7.90-7.84 (dd, 1 H), 8.87-8.76 (dd, 2H), 7.51-7.49 (s, IH), 7.36-7.26 (m, 6H), 7.70-7.
2121
Figure pat00057
Figure pat00057
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.41-8.38(dd,1H), 7.92-7.89(dd,1H), 7.86-7.80(m,4H), 7.76-7.72(m,3H), 7.70-7.66(m,2H), 7.51-7.49(s,1H), 7.36-7.25(m,6H)(Dd, 1H), 8.86-8.76 (dd, 1H), 8.55-8.52 (dd, 1H), 8.41-8.38 2H), 7.51-7.49 (s, IH), 7.36-7. 25 (m, 6H)
2222
Figure pat00058
Figure pat00058
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 7.94-7.92(dd,1H), 7.90-7.83(m,4H), 7.76-7.72(m,3H), 7.70-7.66(m,2H), 7.51-7.49(s,1H), 7.36-7.25(m,6H)(Dd, 1 H), 7.90-7.83 (dd, 1 H), 7.85-8. 2H), 7.51-7.49 (s, IH), 7.36-7. 25 (m, 6H)
2323
Figure pat00059
Figure pat00059
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 7.94-7.92(dd,1H), 7.90-7.84(m,4H), 7.74-7.70(m,3H), 7.70-7.66(m,2H), 7.51-7.49(s,1H), 7.36-7.26(m,6H)(Dd, 1 H), 7.90-7.84 (dd, 1 H), 8.87-8.76 (dd, 2H), 7.51-7.49 (s, IH), 7.36-7.26 (m, 6H), 7.70-7.
2424
Figure pat00060
Figure pat00060
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 7.94-7.92(dd,1H), 7.90-7.83(m,4H), 7.76-7.72(m,3H), 7.70-7.66(m,2H), 7.51-7.49(s,1H), 7.36-7.25(m,6H)(Dd, 1 H), 7.90-7.83 (dd, 1 H), 7.85-8. 2H), 7.51-7.49 (s, IH), 7.36-7. 25 (m, 6H)
2525
Figure pat00061
Figure pat00061
8.82-8.80(dd,1H), 8.78-8.76(dd,1H), 8.55-8.52(dd,1H), 8.40-8.38(dd,1H), 7.92-7.90(dd,1H), 7.88-7.81(m,4H), 7.75-7.71(m,3H), 7.70-7.66(m,2H), 7.51-7.49(s,1H), 7.38-7.26(m,6H)(Dd, 1H), 8.78-8.76 (dd, 1H), 8.55-8.52 (dd, 1H), 8.40-8.38 (dd, 1H), 7.92-7.90 2H), 7.51-7.49 (s, IH), 7.38-7.26 (m, 6H)
2626
Figure pat00062
Figure pat00062
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.54-8.52(dd,1H), 8.41-8.39(dd,1H), 8.18-8.14(dd,1H), 8.00-7.98(dd,1H), 7.94-7.86(m, 4H), 7.77-7.69(m,6H), 7.58-7.51(m,9H), 7.45-7.28(m,5H)(Dd, 1H), 8.78-8.76 (dd, 1H), 8.54-8.52 (dd, 1H), 8.41-8.39 (M, 6H), 7.58-7.51 (m, 9H), 7.45-7.28 (m, 5H)
2727
Figure pat00063
Figure pat00063
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.55-8.53(dd,1H), 8.40-8.38(dd,1H), 8.09-8.07(dd,1H), 7.94-7.92(dd,1H), 7.86-7.84(dd,1H), 7.79-7.77(dd,1H), 7.72-7.70(dd,1H), 7.61-7.59(dd,1H), 7.51-7.44(m, 3H), 7.33-7.24(m,4H), 1.72(s, 6H)(Dd, 1 H), 7.94-7.92 (dd, 1 H), 8.83-8.81 (dd, , 7.86-7.84 (dd, 1H), 7.79-7.77 (dd, 1H), 7.72-7.70 -7.24 (m, 4 H), 1.72 (s, 6 H)
2828
Figure pat00064
Figure pat00064
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.57-8.54(dd,1H), 8.41-8.39(dd,1H), 8.10-8.07(dd,1H), 7.96-7.93(dd,1H), 7.86-7.84(dd,1H), 7.79-7.77(dd,1H), 7.72-7.70(dd,1H), 7.62-7.60(dd,1H), 7.55-7.48(m, 3H), 7.37-7.27(m,4H), 1.72(s, 6H)(Dd, 1H), 8.87-8.76 (dd, 1H), 8.57-8.54 (dd, 1H), 8.41-8.39 , 7.86-7.84 (dd, 1H), 7.79-7.77 (dd, 1H), 7.72-7.70 -7.27 (m, 4 H), 1.72 (s, 6 H)
2929
Figure pat00065
Figure pat00065
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.56-8.54(dd,1H), 8.41-8.39(dd,1H), 8.09-8.07(dd,1H), 7.95-7.93(dd,1H), 7.86-7.84(dd,1H), 7.80-7.78(dd,1H), 7.73-7.71(dd,1H), 7.62-7.60(dd,1H), 7.53-7.46(m, 3H), 7.35-7.26(m,4H), 1.72(s, 6H)(Dd, 1H), 8.78-8.76 (dd, 1H), 8.56-8.54 (dd, 1H), 8.41-8.39 , 7.86-7.84 (dd, 1H), 7.80-7.78 (dd, 1H), 7.73-7.71 -7.26 (m, 4 H), 1.72 (s, 6 H)
3030
Figure pat00066
Figure pat00066
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.56-8.54(dd,1H), 8.40-8.38(dd,1H), 8.18-8.16(dd,1H), 8.12-8.10(dd,1H), 8.00-7.87(m,4H), 7.77-7.69(m,4H), 7.63-7.45(m,8H), 7.33-7.25(m,4H)(Dd, 1H), 8.78-8.76 (dd, 1H), 8.56-8.54 (dd, 1H), 8.40-8.38 (M, 4H), 7.63-7.45 (m, 8H), 7.33-7.25 (m, 4H)
3131
Figure pat00067
Figure pat00067
8.82-8.80(dd,1H), 7.78-7.76(dd,1H), 8.55-8.53(dd,1H), 8.45-8.40(m,2H), 8.05-8.03(dd,1H), 7.98-7.86(m,3H), 7.72-7.68(t,1H), 7.52-7.50(m,3H), 7.33-7.25(m,4H) 2H), 8.05-8.03 (dd, 1H), 7.98-7.86 (m, 2H), 8.82-8.80 (dd, 1H), 7.78-7.76 , 3H), 7.72-7.68 (t, IH), 7.52-7.50 (m, 3H), 7.33-7.25 (m, 4H)
3232
Figure pat00068
Figure pat00068
8.82-8.80(dd,1H), 7.78-7.76(dd,1H), 8.55-8.53(dd,1H), 8.40-8.38(dd,1H), 7.94-7.92(dd,1H), 7.89-7.85(m,3H), 7.72-7.71(d,1H), 7.66-7.62(t,1H), 7.51(s,1H), 7.38-7.28(m,5H), 7.13-7.12(d,1H) (Dd, 1H), 7.87-7.76 (dd, 1H), 8.55-8.53 (dd, 1H), 8.40-8.38 1H), 7.31-7.28 (m, 5H), 7.13-7.12 (d, 1H), 7.72-7.71
3333
Figure pat00069
Figure pat00069
8.83-8.81(dd,1H), 8.78-8.76(dd,1H), 8.55-8.53(dd,1H), 8.40-8.38(dd,1H), 8.12-8.10(dd,1H), 7.94-7.92(dd,1H), 7.86-7.84(dd,1H), 7.72-7.69(t,1H), 7.63-7.50(m,8H), 7.45-7.29(m,6H)(Dd, 1H), 8.84-8.76 (dd, 1H), 8.55-8.53 (dd, 1H), 8.40-8.38 , 7.86-7.84 (dd, 1H), 7.72-7.69 (t, 1H), 7.63-7.50 (m, 8H), 7.45-7.29

실험예 1: 실시예 1의 화합물 1을 사용한 유기 전기발광 소자 제조Experimental Example 1: Production of organic electroluminescence device using Compound 1 of Example 1

박막 두께가 100 nm 인 ITO 투명 전극을 40 mm × 40 mm × 0.7 m 크기로 재단한 기판을 세제가 용해된 증류수 속에서 10 분 동안 초음파로 세정하고, 증류수에서 10 분 동안 2 회 반복 세정하였다. 증류수 세정이 끝나면 아이소프로필알코올, 아세톤, 메탄올 등의 용제를 순차적으로 초음파 세척하고 건조시켰다. 습식정제 후 산소/아르곤 플라즈마를 이용하여 건식세정을 거친 다음 투명 전극 라인을 갖는 유리 기판을 진공 증착 장치의 기판 홀더에 장착하여, 우선 투명 전극 라인이 형성되어 있는 ITO 측의 면상에, 하기 화학식 A로 표시되는 헥사니트릴 헥사아자트리페닐렌을 60 nm의 두께로 열 진공 증착하여 정공 주입층을 형성하였다.An ITO transparent electrode with a thin film thickness of 100 nm was cut to a size of 40 mm × 40 mm × 0.7 m. The substrate was ultrasonically cleaned in distilled water for 10 minutes and washed twice in distilled water for 10 minutes. After the distilled water was washed, solvents such as isopropyl alcohol, acetone and methanol were sequentially ultrasonically washed and dried. After the wet refining, the substrate was dry-cleaned using oxygen / argon plasma, and then a glass substrate having a transparent electrode line was mounted on a substrate holder of a vacuum evaporation apparatus. On the surface of the ITO side on which the transparent electrode line was formed, Hexanitrile hexaazatriphenylene represented by the following formula was thermally vacuum deposited to a thickness of 60 nm to form a hole injection layer.

[화학식 A](A)

Figure pat00070
Figure pat00070

상기 화학식 A로 표시되는 화합물로 된 층 위에 정공 수송을 할 수 있는 하기 화학식 B로 표시되는 화합물(N4,N4 '-di(naphthalen-1-yl)-N4,N4 '-diphenylbiphenyl-4,4'-diamine)의 NPB로 된 층을 20 nm로 진공증착하여 형성하였다.(N 4 , N 4 ' -di (naphthalen-1-yl) -N 4 , N 4 ' -diphenylbiphenyl-Naphthalen-1-yl) which is capable of transporting holes on the layer of the compound represented by Formula 4,4'-diamine) was vacuum-deposited at 20 nm.

[화학식 B][Chemical Formula B]

Figure pat00071
Figure pat00071

상기 화학식 B로 표시되는 화합물로 된 층 위에 전자가 정공 수송층으로 쉽게 흐르는 것을 방지할 수 있는 하기 화학식 C로 표시되는 화합물(N-(4-(4aH-carbazol-9(4bH,8aH,9aH)-yl)phenyl)-N-(4-(9H-carbazol-9-yl)phenyl)-4-(9H-carbazol-9-yl)benzenamine)의 TCTA로 된 층을 10 nm로 진공증착하여 형성하였다.A compound represented by the following formula (C) (N- (4- (4aH-carbazol-9 (4bH, 8aH, 9aH) - yl) phenyl) -N- (4- (9H-carbazol-9-yl) phenyl) -4- (9H-carbazol-9-yl) benzenamine in vacuum at 10 nm.

[화학식 C]≪ RTI ID = 0.0 &

Figure pat00072
Figure pat00072

상기 화학식 C로 표시되는 화합물로 된 층 위에 발광 호스트로서 하기 화학식 D로 표시되는 화합물과 함께, 도판트로서 실시예 1의 화합물 1을 5 중량% 농도로 혼합 증착하여 30nm 두께의 발광층을 형성하였다.Compound 1 of Example 1 was mixed and vapor-deposited at a concentration of 5 wt% as a dopant together with a compound represented by the following formula (D) as a luminescent host on the layer of the compound represented by the formula (C) to form a 30 nm thick luminescent layer.

[화학식 D][Chemical Formula D]

Figure pat00073
Figure pat00073

상기 발광층 위에 전자의 주입 및 수송 역할을 하는 하기 화학식 E의 화합물을 30nm의 두께로 진공 증착하여 형성하였다.A compound of the following formula (E) serving as an electron injecting and transporting layer was vacuum deposited on the light emitting layer to a thickness of 30 nm.

[화학식 E](E)

Figure pat00074
Figure pat00074

상기 전자주입 및 수송층 위에 순차적으로 0.7 nm 두께의 리튬플로라이드(LiF)와 120 nm 두께의 알루미늄을 증착하여 음극을 형성하였다. 상기와 같이 제작된 유기 전기발광 소자에 4V의 전압으로 측정한 결과 전류밀도가 3.73 mA/㎠로 형성되었으며, 이때 1931 CIE 색좌표 기준으로 x=0.148, y=0.192에 해당하는 493 cd/㎡ 밝기의 연청색에 가까운 스펙트럼이 관찰되었으며 효율은 13.2 cd/A 이었다.Lithium fluoride (LiF) with a thickness of 0.7 nm and aluminum with a thickness of 120 nm were sequentially deposited on the electron injection and transport layer to form a cathode. A current density of 3.73 mA / cm < 2 > was measured at a voltage of 4 V in the thus fabricated organic electroluminescent device. The luminance was 493 cd / m < 2 > corresponding to x = 0.148 and y = The near - light spectrum was observed and the efficiency was 13.2 cd / A.

실험예 2: 화합물 2를 사용한 유기 전기발광 소자 제조Experimental Example 2: Preparation of Organic Electroluminescent Device Using Compound 2

발광 도판트 재료인 화합물 1을 대신해 화합물 2를 발광 도판트 물질로서 사용하는 것을 제외하고 유기 전기발광 소자를 실험예 1과 동일한 방식으로 제작하였다. 상기와 같이 제작된 유기 전기발광 소자에 4V의 전압으로 측정한 결과 전류밀도가 2.7 mA/㎠로 형성되었으며, 이때 1931 CIE 색좌표 기준으로 x=0.148, y=0.189에 해당하는 346 cd/㎡ 밝기의 순청색에 가까운 스펙트럼이 관찰되었으며 효율은 12.8 cd/A 이었다.An organic electroluminescent device was prepared in the same manner as in Experimental Example 1 except that Compound 2 was used as a luminescent dopant material in place of Compound 1 as a luminescent dopant material. A current density of 2.7 mA / cm < 2 > was formed on the thus fabricated organic electroluminescent device at a voltage of 4V. The current density was 346 cd / m < 2 > corresponding to x = 0.148 and y = A spectrum close to pure blue was observed and the efficiency was 12.8 cd / A.

비교 실험예 1Comparative Experimental Example 1

화합물 1 대신 하기 화학식 F의 화합물을 발광 도판트 물질로서 사용하는 것을 제외하고는 실험예 1과 동일한 방식으로 제작하였다. 상기와 같이 제작된 유기 전기발광 소자에 4V의 전압으로 측정한 결과 전류밀도가 6.1 mA/㎠로 형성되었으며, 이때 1931 CIE 색좌표 기준으로 x=0.149, y=0.173에 해당하는 329 cd/㎡ 밝기의 순청색에 가까운 스펙트럼이 관찰되었으며 효율은 6.9 cd/A 이었다.Was prepared in the same manner as in Experimental Example 1, except that Compound (F) below was used instead of Compound (1) as a light emitting dopant substance. The organic EL device thus fabricated had a current density of 6.1 mA / cm 2 and a luminance of 329 cd / m 2 corresponding to x = 0.149 and y = 0.173 on the basis of 1931 CIE color coordinates. A spectrum close to pure blue was observed and the efficiency was 6.9 cd / A.

[화학식 F][Chemical Formula F]

Figure pat00075
Figure pat00075

전류밀도
(mA/㎠)
Current density
(mA / cm 2)
밝기
(cd/㎡)
brightness
(cd / m 2)
효율
(cd/A)
efficiency
(cd / A)
색좌표Color coordinates
실험예1(화합물1)Experimental Example 1 (Compound 1) 3.733.73 493493 13.213.2 0.148, 0.1920.148, 0.192 실험예2(화합물2)Experimental Example 2 (Compound 2) 2.72.7 346346 12.812.8 0.148, 0.1890.148, 0.189 비교실험예1(화학식F)Comparative Experimental Example 1 (Formula F) 6.16.1 329329 6.96.9 0.149, 0.1730.149, 0.173

상기 표 1에서 보는 바와 같이, 본 발명의 화합물을 사용한 유기전기발광소자는 비교 실험예 1의 유기전기발광소자에 비하여 효율이 훨씬 높았으며, 밝기가 높았으며, 전류밀도는 낮았다.As shown in Table 1, the organic electroluminescent device using the compound of the present invention had much higher efficiency, higher brightness, and lower current density than the organic electroluminescent device of Comparative Experiment Example 1. [

Claims (7)

하기 화학식 1로 표시되는 화합물:
[화학식 1]
Figure pat00076

상기 식에서,
R1은 단일결합, -CH2-, S 또는 O이고, 상기 R2 내지 R3은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 치환된 탄소수 6 내지 40의 아릴기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기, 치환 또는 비치환된 탄소수 2 내지 60의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 60의 알키닐기, 치환 또는 비치환된 탄소수 3 내지 60의 시클로알킬기 및 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기 중에서 선택되는 어느 하니이고,
임의적으로 상기 R1 내지 R3은 각각 독립적으로 탄소수 1 내지 6의 알킬로 치환 또는 비치환된 탄소수 6 내지 50의 아릴, 탄소수 1 내지 50의 알킬 및 탄소수 3 내지 50의 사이클로알킬로 구성되는 군으로부터 선택되는 어느 하나 이상의 치환기로 치환될 수 있다.
A compound represented by the following formula (1):
[Chemical Formula 1]
Figure pat00076

In this formula,
R 1 is a single bond, -CH 2 -, S or O, each of R 2 to R 3 independently represents hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted group having 6 to 40 A substituted or unsubstituted aryl group having 2 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 60 carbon atoms, a substituted or unsubstituted alkynyl group having 2 to 60 carbon atoms, A cycloalkyl group having 3 to 60 carbon atoms, and a substituted or unsubstituted cycloalkenyl group having 5 to 30 carbon atoms,
Optionally, R 1 to R 3 are each independently selected from the group consisting of C 6 -C 50 aryl, C 1 -C 50 alkyl, and C 3 -C 50 cycloalkyl substituted or unsubstituted with alkyl having 1 to 6 carbons And may be substituted with any one or more substituents selected.
제1항에 있어서,
상기 R2 및 R3는 각각 독립적으로 수소, 중수소, 카바졸(carbazole), 아크리딘(droacridine), 페노시아진(phenothiazine), 페녹사진(phenoxazine), 디벤조퓨란(dibenzofuran), 디벤조티오펜(dibenzothiophene) 및 페닐카바졸(phenylcarbazole)로 이루어진 군에서 선택되는 어느 하나이고,
R1, R2 및 R3는 서로 결합하여 잔텐(xanthene)을 형성할 수 있고,
R2 및 R3는 각각 인접한 탄소와 결합하여 벤조퓨란(benzofuran), 벤조티오펜(hydrobenzothiophene), 인덴(indene) 또는 인돌린(indoline)을 형성할 수 있으며,
임의적으로 상기 R1 내지 R3은 각각 독립적으로 탄소수 1 내지 6의 알킬로 치환 또는 비치환된 탄소수 6 내지 50의 아릴, 탄소수 1 내지 50의 알킬 및 탄소수 3 내지 50의 사이클로알킬로 구성되는 군으로부터 선택되는 어느 하나 이상의 치환기로 치환될 수 있다.
The method according to claim 1,
Wherein R 2 and R 3 are each independently selected from the group consisting of hydrogen, deuterium, carbazole, droacridine, phenothiazine, phenoxazine, dibenzofuran, dibenzothi Dibenzothiophene, and phenylcarbazole. In the present invention,
R 1 , R 2 and R 3 may combine with each other to form a xanthene,
R 2 and R 3 may each combine with adjacent carbons to form benzofuran, hydrobenzothiophene, indene or indoline,
Optionally, R 1 to R 3 are each independently selected from the group consisting of C 6 -C 50 aryl, C 1 -C 50 alkyl, and C 3 -C 50 cycloalkyl substituted or unsubstituted with alkyl having 1 to 6 carbons And may be substituted with any one or more substituents selected.
제1항에 있어서, 상기 화합물은
Figure pat00077

Figure pat00078


Figure pat00079

Figure pat00080

Figure pat00081

Figure pat00082

Figure pat00083

로 구성되는 군으로부터 선택되는 화합물인 것을 특징으로 하는 화합물.
The compound according to claim 1, wherein the compound is
Figure pat00077

Figure pat00078


Figure pat00079

Figure pat00080

Figure pat00081

Figure pat00082

Figure pat00083

≪ / RTI > is a compound selected from the group consisting of < RTI ID = 0.0 >
제1항 내지 제3항 중 어느 한 항의 화합물을 함유하는 유기전기발광소자용 발광 호스트 또는 도판트 함유 조성물.A light emitting host or a dopant-containing composition for an organic electroluminescence device containing the compound of any one of claims 1 to 3. 양극, 음극, 및 상기 두 전극 사이에 제1항 내지 제3항 중 어느 한 항의 화합물을 함유하는 유기층을 포함하는 유기전기발광소자.An organic electroluminescent device comprising an anode, a cathode, and an organic layer containing a compound of any one of claims 1 to 3 between the two electrodes. 제5항에 있어서, 상기 유기층이 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 또는 이들의 적층체인 것이 특징인 유기전기 발광소자.The organic electroluminescent device according to claim 5, wherein the organic layer is a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, or a laminate thereof. 제5항에 있어서, 상기 제1항 내지 제3항 중 어느 한 항의 화합물이 발광 호스트 물질 또는 도판트 물질로서 사용되는 것이 특징인 유기전기발광소자.The organic electroluminescent device according to claim 5, wherein the compound of any one of claims 1 to 3 is used as a light emitting host material or a dopant material.
KR1020160055435A 2016-05-04 2016-05-04 Organic compound comprising pyrimidine and organic electroluminescent device comprising the same KR101977352B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160055435A KR101977352B1 (en) 2016-05-04 2016-05-04 Organic compound comprising pyrimidine and organic electroluminescent device comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160055435A KR101977352B1 (en) 2016-05-04 2016-05-04 Organic compound comprising pyrimidine and organic electroluminescent device comprising the same

Publications (2)

Publication Number Publication Date
KR20170126059A true KR20170126059A (en) 2017-11-16
KR101977352B1 KR101977352B1 (en) 2019-05-14

Family

ID=60806887

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160055435A KR101977352B1 (en) 2016-05-04 2016-05-04 Organic compound comprising pyrimidine and organic electroluminescent device comprising the same

Country Status (1)

Country Link
KR (1) KR101977352B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200116722A (en) * 2019-04-02 2020-10-13 한국교통대학교산학협력단 Heteroaromatic derivative compound for organic electroluminescent device and organic electroluminescent device comprising the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120292603A1 (en) * 2011-05-09 2012-11-22 Yoon-Hyun Kwak Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device
KR20170042423A (en) * 2015-10-08 2017-04-19 삼성디스플레이 주식회사 Condensed-cyclic compound and organic light emitting device comprising the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120292603A1 (en) * 2011-05-09 2012-11-22 Yoon-Hyun Kwak Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device
KR20170042423A (en) * 2015-10-08 2017-04-19 삼성디스플레이 주식회사 Condensed-cyclic compound and organic light emitting device comprising the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200116722A (en) * 2019-04-02 2020-10-13 한국교통대학교산학협력단 Heteroaromatic derivative compound for organic electroluminescent device and organic electroluminescent device comprising the same

Also Published As

Publication number Publication date
KR101977352B1 (en) 2019-05-14

Similar Documents

Publication Publication Date Title
JP6100368B2 (en) Biscarbazole derivative host material and green light emitter for OLED light emitting region
JP5926421B2 (en) Biscarbazole derivative and organic electroluminescence device using the same
KR101142056B1 (en) Novel aromatic derivatives and organic electroluminescent device comprising same
KR20110123106A (en) Organic electroluminescence derivative and device using the phenanthrocarbazole
JP2016153394A (en) Indenotriphenylene-based amine derivative for organic electroluminescent device
KR20140125061A (en) An organoelectro luminescent compound and an organoelectroluminescent device using the same
JP2016155797A (en) Organic material and organic electroluminescent element using the same
TWI719456B (en) Heteroaromatic compound and organic electroluminescence device using the same
KR101311840B1 (en) Novel tetiary aryl amine and organic electroluminescent device using the same
KR20180131662A (en) Novel pyridinyl triazolopyridine derivatives and use thereof
KR20140127705A (en) Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same
KR20110084508A (en) Aromatic derivatives and organic electroluminescent device comprising same
KR101977352B1 (en) Organic compound comprising pyrimidine and organic electroluminescent device comprising the same
JP6420889B2 (en) Compound and organic electronic device using the same
KR102174388B1 (en) Cyclic compound and organic light emitting device comprising the same
KR101822987B1 (en) Spyro-typed organic material and organic electroluminescent device utilizing the same
KR102098920B1 (en) Organic compound comprising boron and organic electroluminescent device comprising the same
JP6498243B2 (en) Compound and organic electronic device using the same
JP6539821B2 (en) Compound and organic electronic device using the same
KR20150114658A (en) An organoelectro luminescent compounds and organoelectro luminescent device using the same
KR101883772B1 (en) Benzimidazole derivatives and organic electroluminescent device comprising same
KR20180124784A (en) Hetero-cyclic compound and organic light emitting device comprising the same
KR20110065415A (en) Aromatic derivatives and organic electroluminescent device comprising same
KR101822993B1 (en) Spyro-typed organic material and organic electroluminescent device utilizing the same
KR20150136712A (en) Aromatic sulfone derivatives and Organic electroluminescent device comprising same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right